CURRICULUM VITAE
Paula E. North MD, PhD
Paula E. North MD, PhD
Professor
Department of Pathology
Division of Pediatric Pathology
Department of Pathology
Division of Pediatric Pathology
OFFICE ADDRESS: |
Children’s Wisconsin - Milwaukee Hospital |
8915 W Connell Court |
Milwaukee, WI 53226 |
EDUCATION: |
09/1972 - 05/1974 B.A., Biology (High Distinction), University of Virginia, Charlottesville, VA |
01/1975 - 05/1982 Ph.D., Molecular Biology, Vanderbilt University, Nashville, TN |
07/1988 - 05/1992 M.D., University of Arkansas for Medical Sciences, Little Rock, AR |
POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS: |
1982 - 1984 RESEARCH: Postdoctoral Fellow, Physiology Vanderbilt University School of Medicine, Nashville, TN |
1992 - 1995 CLINICAL: Resident in Pathology (Anatomic and Clinical), University of Arkansas for Medical Sciences, School of Medicine, Little Rock, AR |
FACULTY APPOINTMENTS: |
01/1981 - 05/1991 Lecturer in Molecular Biology, Vanderbilt University, Nashville, TN |
07/1995 - 06/2001 Assistant Professor of Pathology, University of Arkansas for Medical Sciences, School of Medicine, Little Rock, AR |
07/2001 - 06/2005 Associate Professor of Pathology with Tenure University of Arkansas for Medical Sciences, School of Medicine, Little Rock, AR |
07/2005 - 09/2005 Professor of Pathology with Tenure, University of Arkansas for Medical Sciences, School of Medicine, Little Rock, AR |
09/2005 - Present Professor of Pathology with Tenure, Traditional Pathway, Medical College of Wisconsin, Milwaukee, WI |
04/2009 - Present Adjunct faculty, University of Wisconsin, Milwaukee, WI |
07/2013 - Present Professor, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, WI |
ADMINISTRATIVE APPOINTMENTS: |
07/2001 - 09/2005 Vice-Chief, Pediatric Pathology, University of Arkansas for Medical Sciences |
09/2005 - Present Chief, Department of Pathology and Laboratory Medicine, Children's Hospital of Wisconsin Medical and Dental Staff |
09/2005 - 12/2014 Specialty Practice Unit Leader, Pathology, Children's Specialty Group, Medical College of Wisconsin |
09/2005 - 12/2014 Chief, Pediatric Pathology, Medical College of Wisconsin |
11/2018 - Present Chief Laboratory Officer, TAI Diagnostics, Inc. |
EDUCATIONAL ADMINISTRATIVE APPOINTMENTS: |
09/1995 - 05/2001 Section Leader, Gastrointestinal Pathology, Sophomore Pathophysiology Course, University of Arkansas for Medical Sciences, Medical School |
07/1998 - 06/2003 Director, Pediatric Clinical Pathology Resident Rotation, University of Arkansas for Medical Sciences, Medical School |
07/1999 - 06/2002 Director, Pediatric Molecular Pathology Rotation, University of Arkansas for Medical Sciences |
09/2005 - 2008 Residency Director, Pediatric Pathology, Children's Hospital of Wisconsin |
07/2012 - Present Global Health Pathway Mentor, Medical College of Wisconsin |
09/2012 - 05/2015 Fellowship Director, Pediatric Pathology, Children's Hospital of Wisconsin |
HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS: |
09/1995 - 01/2005 Director of Clinical Pathology, Arkansas Children's Hospital |
09/1995 - 07/2000 Director, Hematology Division, Arkansas Children's Hospital Clinical Laboratory |
09/1995 - 08/2005 Director, Clinical Chemistry Division, Arkansas Children's Hospital Clinical Laboratory |
09/1995 - 10/1996 Director, Blood Bank, Arkansas Children's Hospital (Interim Director 2001-2003) |
10/1996 - 08/2005 Medical Director (and Founder), Molecular Diagnostics Laboratory, Arkansas Children's Hospital |
01/1998 - 04/2004 Co-Director, Vascular Anomalies Center, Arkansas Children's Hospital |
07/2003 - 06/2005 Secretary-Treasurer, Medical Staff, Arkansas Children's Hospital |
07/2005 - 09/2005 Vice-Chief of Staff, Arkansas Children's Hospital |
09/2005 - Present Executive Committee, Vascular Anomalies Center, Children's Hospital of Wisconsin |
09/2005 - 12/2014 Medical Director, Pathology and Laboratory Medicine, Children's Hospital of Wisconsin |
08/2008 - 12/2014 Medical Director, CHW New Berlin Laboratory, Children's Hospital of Wisconsin |
07/2015 - Present Medical Director, TAI Diagnostics, Inc., Wauwatosa, WI |
RESEARCH ADMINISTRATIVE APPOINTMENTS: |
01/1998 - 09/2005 Research Director, Vascular Anomalies Center, Arkansas Children's Hospital, Little Rock |
09/2005 - 12/2014 Founding Director, CRI Imaging Core Research Laboratory, Children's Health and Hospital System, Milwaukee |
09/2005 - Present Founding Director, CRI Histology Core Research Laboratory, Children's Health and Hospital System, Milwaukee |
02/2008 - 07/2014 Founding Director, Pediatric BioBank and Tissue Analytical Core, Children's Health and Hospital System, Milwaukee |
07/2012 - Present Deputy Director, NIH/NIEHS Children's Environmental Health Sciences Core Center, Milwaukee |
11/2018 - Present Clinical Trials Director, TAI Diagnostics, Inc., Milwaukee |
HOSPITAL STAFF PRIVILEGES: |
08/1995 - 2005 John L. McClellan Memorial Veteran's Hospital, Little Rock, AR |
08/1995 - 2005 University Hospital, Little Rock, AR |
08/1995 - 2007 Arkansas Children's Hospital, Little Rock, AR |
09/2005 - Present Children's Hospital of Wisconsin, Milwaukee, WI |
06/2008 - Present Froedtert Hospital, Milwaukee |
SPECIALTY BOARDS AND CERTIFICATION: |
Board Certified | Issue Date | Expiration |
American Board of Pathology: Anatomic and Clinical Pathology | 11/13/1996 | None |
American Board of Pathology: Pediatric Pathology | 08/20/1999 | None |
Licensure | Number | Issue Date | Expiration |
Arkansas | 08/10/1992 | 07/31/2011 | |
Wisconsin | 06/30/2005 | 10/2018 | |
AWARDS AND HONORS: |
1974 - Present Graduation with High Distinction, University of Virginia |
1975 - Present Vanderbilt University Scholar |
1978 - Present Ethel Mae Wilson Special Award for Dissertation Research, Vanderbilt University |
1979 - Present Vanderbilt University Scholar |
1989 - Present Buchanan Key, University of Arkansas for Medical Sciences |
1989 - Present Neuroscience Award, University of Arkansas for Medical Sciences |
1989 - Present Frank Williams Scholarship, University of Arkansas for Medical Sciences |
1990 - Present Hans G. Schlumberger Award in Pathology, University of Arkansas for Medical Sciences |
1990 - Present Barton Scholarship, University of Arkansas for Medical Sciences |
1990 - Present American Society of Clinical Pathologists Award for Academic Excellence |
1992 - Present Richard J. Webber Research Award, University of Arkansas for Medical Sciences |
1992 - Present American Medical Women's Association Scholarship Achievement Citation |
1992 - Present Faculty Gold Key, University of Arkansas for Medical Sciences, School of Medicine |
2000 - Present Lucien J. Rubenstein Award, Second Place, American Association of Neuropathologists |
2000 - Present John Mulliken Award for Research, International Society for the Study of Vascular Anomalies, Montreal, Canada |
2008 - 2017 Best Doctors in America |
2012 - Present Top Doctors, US News & World Report |
2015 - Present Physician of the Year, Vascular Birthmarks Foundation |
MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES: |
Phi Sigma Honorary Scientific Society |
Sigma Xi Honorary Scientific Society |
Alpha Omega Alpha Honorary Medical Society |
United States and Canadian Academy of Pathology |
College of American Pathology (Fellow) |
Association for Molecular Pathology |
Society for Pediatric Pathology |
International Society for Heart & Lung Transplantation (ISHLT) |
Patient-Centered Laboratory Utilization Guidance Services Network |
Vascular Birthmarks Foundation |
Sturge-Weber Foundation |
International Society for the Study of Vascular Anomalies (ISSVA) |
NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS: |
2001 - Present Scientific Review Panel, ad hoc, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (P01 review) |
2001 - Present Committee on Interferons: Biological Mechanisms and Disease Treatments II (Judah Folkman and Ernest Borden, organizers) Cold Spring Harbor Laboratory, New York, September 9-11, 2001. |
2002 - Present Rare Tumor Group, World Health Organization Committee, Coordinating Center Milan, Italy. |
2002 - Present Scientific Review Panel, ad hoc, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (P01 review). |
2002 - Present Ad-hoc Reviewer, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Study Section, National Institutes of Health (R21 review). |
2003 - Present Scientific Review Panel, ad hoc, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH (P01 review). |
2004 - Present Special Emphasis Panel, ad hoc, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Feb 2004 (S11 review). |
2004 - Present Scientific Review Panel, ad hoc, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH (P01 review). |
2004 - Present Organizing Committee, NIH-sponsored Hemangioma Research Workshop, Bethesda, Maryland, April 7-9, 2005. |
2004 - Present Special Emphasis Panel, ad hoc, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, July 2004 (S11 review). |
2005 - Present Special Emphasis Panel, ad hoc, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, Sept 2005 (S11 review). |
2006 - Present Medical and Scientific Advisor, National Organization for Vascular Anomalies. |
2008 - 2014 Scientific Committee, International Society for the Study of Vascular Anomalies. |
2008 - Present Medical Advisory Council, Lymphangiomatosis & Gorham's Disease Alliance, Boca Raton, FL. |
2009 - Present Inspection Team Leader and Molecular Inspector, College of American Pathologists. |
2009 - Present Internal Advisory Committee, Children's Environmental Health Science Center (NIH/NIEHS). |
2011 - Present Consensus Committee, Lymphangiomatosis & Gorham's Disease Alliance. |
06/24/2015 - Present Scientific Reviewer, FY15 Peer Reviewed Medical Research Program (Department of Defense) Pre-Application Vascular Malformations Focused Program Award Panel. |
12/18/2015 - Present Chairman, FY15 Peer Reviewed Medical Research Program (Department of Defense) Vascular Malformations Focused Program Award Panel. |
2015 - Present Chair, Tissue Repository Committee, Sturge-Weber Foundation. |
12/21/2016 - Present Chairman, FY16 Peer Reviewed Medical Research Program (Department of Defense) Vascular Malformations Focused Program Award Panel. |
09/2017 - Present Ad hoc Committee, Harvard University Promotions |
12/20/2017 - Present Chairman, FY17 Peer Reviewed Medical Research Program (Department of Defense) Vascular Malformations Focused Program Award Panel. |
2019 - Present Medical Co-Director, Vascular Birthmarks Foundation (International) |
RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
INVITED LECTURES/WORKSHOPS/PRESENTATIONS: |
International |
Invited Symposium Speaker (2 lectures), 1) Histopathology of Vascular Birthmarks, 2) Frontiers of Research in Vascular Anomalies. American Academy of Dermatology Symposium, 58th Annual Meeting, Vascular Birthmarks: Diagnosis and Management for the Millennium, San Francisco, California, 03/11/2000 |
Invited Speaker, 13th International Workshop on Vascular Anomalies, "New Immunohistochemical Findings in Juvenile Hemangioma: GLUT1 and Beyond.", Intl Society for the Study of Vascular Anomalies, Montreal Canada, 05/11/2000 |
Guest Lecturer, Department of Genetics, "The Role of Pathology in Translational Research", Duke University, Durham, NC, 05/31/2000 |
"Hemangiogenesis: New Targets for Therapy, 06/05/2000 |
Invited International Speaker (2 lectures), "Histopathological Diagnosis of Vascular Anomalies of Childhood" and "New Insights into the Pathogenesis of Infantile Hemangioma." Center for Study and Treatment of Vascular Anomalies, Hutt Hospital, Wellington, New Zealand, 04/03/2001 |
Guest Faculty, Second Annual CME Course on Vascular Anomalies (Speaker), "Unique Immunophenotypic Features of Juvenile Hemangioma: Implications for Pathogenesis." New York University, 05/18/2001 |
Grand Rounds Lecturer, "The Pathogenesis of Infantile Hemangioma." Massachusetts General Hospital, Department of Pathology, Boston, Massachusetts, 05/30/2001 |
Co-chair, Kasabach Merritt Syndrome Symposium, IXth International Congress of Pediatric Dermatology, Cancun, Mexico, 10/22/2001 |
Co-chair, Clinicopathological Correlations, IXth International Congress of Pediatric Dermatology, Cancun, Mexico, 10/24/2001 |
Symposium Speaker, IXth International Congress of Pediatric Dermatology, "Vascular Tumors and KMP Past and Present: the Pathologist's Point of View." Symposium entitled: KasabachMerritt Syndrome, " Cancun, Mexico, 10/2001 |
Symposium speaker, IXth International Congress of Pediatric Dermatology, "The Histopathology of Hemangiomas" Symposium entitled: Vascular Anomalies. What's New? Cancun, Mexico, 10/2001 |
Moderator, Basic Science Session, International Society for the Study of Vascular Anomalies, 14th annual Workshop, Nijmegen, the Netherlands, 06/2002 |
Mega-Rounds Speaker, Department of Dermatology, Harvard University (Brigham and Women's Hospital), "Infantile Hemangioma: A Link to the Placenta", 02/06/2003 |
Symposium Speaker, American Academy of Dermatology, 61st Annual Meeting, Vascular Birthmarks Symposium, San Francisco, California, "The Histopathology of Vascular Birthmarks: Basic Criteria, Problem Areas, and Recent Advances, 03/22/2003 |
Workshop (CME) Director and Speaker (with Dr. Harry Kozakewich), Society for Pediatric Pathology, "Vascular Tumors and Malformations in Children", Washington, D.C., 03/23/2003 |
Invited Speaker, 2003 Port Wine Stain Conference, sponsored by the Vascular Birthmarks Foundation and the Skin Surgery Center of New York, "Port Wine Stains: Through the Looking Glass, New York University, New York, NY, 10/18/2003 |
Faculty, 6th Annual UAMS Anatomic Pathology Conference (CME), "Vascular Tumors and Malformations of Childhood: New Diagnostic Criteria, " Peabody Hotel, Little Rock, AR, 10/19/2003 |
Grand Rounds Speaker, Department of Pathology, University of California at Davis, Sacramento, CA, 12/11/2003 |
Grand Rounds Speaker, Department of Pathology, Stanford University, Palo Alto, California, 01/28/2004 |
Moderator, International Society for the Study of Vascular Anomalies, 15th Annual Workshop, Wellington, New Zealand, 02/24/2004 |
Workshop (CME) Director and Speaker (with Dr. Harry Kozakewich), Society for Pediatric Pathology, "Vascular Tumors and Malformations in Children", Vancouver, BC, 03/06/2004 |
Keynote Speaker, Tenth World Congress of Pediatric Dermatology, Angiomas: Pathological Findings and Clinical Consequences", Rome, Italy, 07/09/2004 |
Short Course Speaker, International Academy of Pathology, Sun-Induced Diseases, "Photosensitive Genodermatoses, " Brisbane, Australia, Brisbane, Australia., 10/12/2004 |
Short Course Speaker, International Academy of Pathology, Vascular Pathology (Drs Henry Tazelaar and Edwina Duhig, chairs), "Vascular Neoplasia, " Brisbane, Australia, 10/12/2004 |
Invited Speaker, "Vascular Tumors and Malformations - A View through the Looking Glass", Skåne University Hospital, Malmo, Sweden, 10/22/2004 |
International Guest Lecturer, Nordic Vascular Tumor Day, Malmo, Sweden, 10/22/2004 |
Workshop (CME) Director and Speaker (with Dr. Harry Kozakewich), Society for Pediatric Pathology, "Vascular Tumors and Malformations in Children", San Antonio, TX, 02/27/2005 |
Plenary Session Lecturer, NIH-sponsored Hemangioma Research Workshop, "Histopathology and Molecular Phenotype", Bethesda, Maryland, 04/08/2005 |
Co-Chair and Speaker, Basic/Translational Research break-out session, NIH-sponsored Hemangioma Research Workshop, Bethesda, Maryland, 04/09/2005 |
Guest Faculty, Fourth Annual CME Course on Vascular Anomalies, New York University, "Evidence for Immune Tolerance in the Development of Infantile Hemangioma, New York, NY, 05/14/2005 |
Invited Speaker, "Unraveling the Mystery of Infantile Hemangioma - Recent Advances in Diagnosis and Research", American Society of Pediatric Otolaryngology Annual Meeting, 05/30/2005 |
Invited Short Course Speaker, "Vascular Tumors", European Academy of Pathology Annual Meeting, Paris, France, 09/05/2005 |
Visiting Professor, Department of Pathology, Indiana University, 10/05/2005 |
Visiting Professor, Department of Cell Biology, Harvard Medical School, Boston, MA, 11/14/2005 |
Invited Speaker, Editor's Choice Pediatric Conference, sponsored by Children's Hospital of Wisconsin, Pfister Hotel, 06/01/2006 - 06/02/2006 |
Invited Round Table Discussion Leader, "Controversies in Vascular Malformations", International Society for the Study of Vascular Anomalies, Milan, Italy, 06/2006 |
Visiting Professor, Department of Pathology, Children's Hospital of Philadelphia, Philadelphia, PA, 01/09/2007 - 01/10/2007 |
Visiting Professor, Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, 01/23/2007 - 01/24/2007 |
Invited Speaker, Best Practices in Pediatrics - Winter 2007 Conference, Wilderness Resort, Wisconsin, 03/03/2007 |
Keynote Speaker, "Understanding Infantile Hemangioma: a Story of Discovery and Hope", Vascular Anomalies CME Course, New York University, New York, NY, 04/27/2007 |
Invited Speaker, Point-Counterpoint - Vascular Anomalies, New York University, New York, NY, 04/2007 |
Invited Speaker, "Vascular Tumors Associated with Coagulopathy", Haemangioma Vascular Malformations Center, Clinical & Integration Offsite Retreat, Cincinnati, OH, 12/14/2007 |
Invited Speaker, Vascular Anomalies Panel, American Society for Pediatric Otolaryngology Annual Meeting, Orlando, FL, 05/03/2008 |
Invited Speaker, "Vascular Malformations of the Head and Neck: a Biological Approach to Classification", American Society for Pediatric Otolaryngology Annual Meeting, Orlando, FL, 05/04/2008 |
Chair, Difficult Case Panel, International Society for the Study of Vascular Anomalies, 17th Annual Workshop, Boston, MA, 06/23/2008 |
Keynote Speaker, International Society for the Study of Vascular Anomalies, 17th Annual Workshop, Boston, MA "New Insights into Vascular Anomalies: a Pictorial Essay", 06/24/2008 |
Invited Speaker, "Molecular Mechanisms in the Pathogenesis of Venous Malformations", American Society for Pediatric Otolaryngology Annual Meeting, Seattle, WA, 05/22/2009 |
Invited Speaker, XIX ENT World Congress IFOS 2009 Brazil, Sao Paulo, Brazil, 06/02/2009 |
Invited Speaker, "The Life of an Endothelial Cell in Infantile Hemangioma", Children's Hospital of Philadelphia, Philadelphia, 07/2009 |
Invited Speaker, International Vascular Anomalies Symposium, University of Arkansas for Medical Sciences, 10/09/2009 |
Invited Moderator and Panelist, Pediatric Pathology Specialty Conference (CME) on Vascular Pathology, USCAP, 03/2010 |
Invited Speaker, Pathology Grand Rounds, University Hospitals Case Medical Center, Cleveland, OH, 04/14/2010 |
Invited Speaker, North Carolina Dermatological Society, University of North Carolina Hospitals, Asheville, NC, 08/07/2010 |
Invited Grand Rounds Speaker, Children's Memorial Hospital, Chicago, IL, 08/18/2010 |
Invited Speaker, Departamento de Patología, Instituto Nacional de Enfermedades Neoplasicas, Surgery, Lima, Peru, 09/15/2010 - 09/16/2010 |
Virginia H. and Russell McFarland Annual Lecturer in Pediatric Pathology, Texas Children's Hospital, Houston, TX, 01/21/2011 |
Invited participant and speaker, Lymphatic Malformations Consensus Meeting, Children's Hospital Boston, 02/05/2011 |
Invited Speaker, Society for Pediatric Pathology Fall Meeting, Research Update for Pathologists, "Vascular Anomalies - Recent Research Findings, New Investigational Tool, and Continuing Challenges", Milwaukee, WI, 10/01/2011 |
Invited Speaker, The Korean Dermatological Association's 63rd Annual Autumn Meeting, Seoul, Korea, 10/15/2011 - 10/16/2011 |
Invited Speaker, 1st Meeting of the German Network of Vascular Anomalies, Berlin, Germany, 10/28/2011 - 10/29/2011 |
Invited Speaker, "Clinical Use of Whole Genome and Whole Exome Sequencing Today", College of American Pathologists, Whole Genome Sequencing Webinar, 12/11/2011 |
Workshop Speaker, Intl Society for Biological & Environmental Repositories Annual Meeting - "Telepathology and Biobanking in Remote International Locations", Vancouver, British Columbia, Canada, 05/15/2012 - 05/18/2012 |
Invited Speaker, 19th International Workshop on Vascular Anomalies, International Society for the Study of Vascular Anomalies, Basic Course, "Histopathology of Vascular Anomalies for Pathologists", Malmo, Sweden, 06/16/2012 |
Invited Tutor, International Paediatric Pathology Association XXXIVth Advanced Course in Paediatric Pathology (multiple lectures over 1 week period), La Granja, Spain, 09/2012 |
Invited Speaker, XXI Peruvian Congress of Anatomic Pathology, Cuzco, Peru, 11/2012 |
Invited Speaker, San Martin Department of Health, Moyobamba City Hall, Moyobamba, Peru, 02/13/2013 |
Invited Speaker, New York Academy of Sciences - Controversies in Vascular Anomalies, New York City, New York, 05/03/2013 - 05/04/2013 |
Invited Speaker, "Exposure and Biological Analysis Core", Children's Environmental Health Sciences Core Center All Investigator Meeting, Milwaukee, 05/28/2013 |
Invited Speaker, 1st International Conference on Generalized Lymphatic Anomaly and GorhamStout Syndrome, Bethesda, MD, 06/07/2013 - 06/08/2013 |
Invited Speaker, "Clinicopathological Correlation: Vascular...or Not?", 39th Annual Meeting of the Society for Pediatric Dermatology, Milwaukee, Wisconsin, 07/11/2013 - 07/14/2013 |
Invited Speaker, Department of Pathology, Auckland Hospital, Auckland, New Zealand, 10/2013 |
Invited Organizing Moderator and Keynote Speaker, day-long International Workshop for Pathologists - "The Pathology of Vascular Lesions", Royal Children's Hospital, Melbourne, Australia, 03/31/2014 |
Chair, Basic Science Session, 20th International Workshop on Vascular Anomalies, International Society for the Study of Vascular Anomalies, Melbourne, AU, 04/03/2014 |
Invited moderator and speaker (multiple lectures), Workshop on the Classification of Vascular Anomalies, XIVth Scientific Meeting of the Eastern China Cooperative Group of Pediatric Pathologists, Shanghai, China, 04/12/2014 - 04/14/2014 |
Invited speaker, Vascular Birthmarks Foundation 20th Anniversary Conference and Gala, New York, NY, 10/10/2014 - 10/11/2014 |
Invited Speaker, "The Diagnostic Challenge of Pediatric Vascular Tumors and Malformations", University of Wisconsin - Madison, Department of Pathology Grand Rounds, Madison, WI, 02/06/2015 |
Invited Speaker and Panelist, Sturge-Weber Research Conference (NIH-funded), Bethesda, MD, 04/19/2015 - 04/20/2015 |
Keynote Speaker and 3 lectures, Nordic Society for Vascular Anomalies Annual Meeting, with afternoon Workshop for Pathologists, Oslo, Norway, 05/27/2015 |
Co-Chair and Speaker, Program Session (CME) on Vascular Tumors - Benign and Malignant, 23rd World Congress of Dermatology, Vancouver, Canada, 06/10/2015 |
Invited Professorship in Vascular Anomalies, Texas A&M Health Science Center College of Medicine, 10/07/2015 - 10/08/2015 |
Inviter Speaker and Award Recipient (Physician of the Year) Vascular Birthmarks Foundation, San Diego, CA, 10/14/2015 |
Invited Speaker, Paediatric Pathology Society and ANZ Paediatric Pathology Group Joint Scientific Meeting 2015, Perth, AU, 11/21/2015 |
Invited Tutor (multiple lectures), International Paediatric Pathology Association Update Pediatric Pathology Course, Margaret River, Australia, 11/22/2015 - 11/27/2015 |
Keynote Speaker, EADV Fostering Course in Vascular Anomalies, Malmö, Sweden, 03/08/2016 |
Chair, Basic Science Session, 21st International Workshop on Vascular Anomalies, International Society for the Study of Vascular Anomalies, Buenos Aires, AR, 04/27/2016 |
Chair, Difficult Case Presentations II, 21st International Workshop on Vascular Anomalies, 04/28/2016 |
International Society for the Study of Vascular Anomalies, Buenos Aires, AR, 04/28/2016 |
Invited speaker, 2nd International Conference on Generalized Lymphatic Anomaly and GorhamStout Disease, Atlanta, GA, 06/10/2016 - 06/11/2016 |
Invited Lecturer and Tutor, Dermapedia Comprehensive Course (CME) on Soft Tissue Tumors (three lectures), San Diego, CA, 04/20/2017 - 04/22/2017 |
Invited Faculty, "Cases and Controversies in Vascular Anomalies", at the New York Academy of Sciences, 7 World Trade Center, New York, NY, 05/05/2017 - 05/06/2017 |
Invited speaker, Association of Public Health Laboratories 2017 Annual Meeting, "Strengthening Laboratory System Partnerships -- Building Global Health Capacity Beyond Jurisdictions", Providence, Rhode Island, 06/14/2017 |
Invited Speaker and Tissue Banking Subgroup Leader, Sturge-Weber Foundation Clinical Care Network Conference, New Orleans, LA, 10/01/2017 - 10/02/2017 |
Invited Lecturer, "Hemangiomas", Primer Course in Vascular Anomalies, Amsterdam, The Netherlands, in conjunction with the 22nd International Workshop of the International Society for the Study of Vascular Anomalies, 05/28/2018 |
Invited Speaker and Moderator (3 lectures), Advanced Course in Pathology of Vascular Anomalies, Amsterdam, The Netherlands, in conjunction with the 22nd International Workshop of the International Society for the Study of Vascular Anomalies, 05/29/2018 |
Chair and Keynote Speaker, Day-long International Conference on the Histopathologic and Molecular Diagnosis of Vascular Anomalies, Amsterdam, The Netherlands, in conjunction with the 22nd International Workshop of the International Society for the Study of Vascular Anomalies, 06/2018 |
Invited Lecturer, Bone and Soft Tissue Pathology Society Companion Course on Vascular lesions, "Pediatric Vascular Tumors and Malformations", 2019 Annual Meeting of the United States and Canadian Academy of Pathology, 03/17/2019 |
National |
Invited Symposium Speaker (2 lectures), 1) Histopathology of Vascular Birthmarks, 2) Frontiers of Research in Vascular Anomalies. American Academy of Dermatology Symposium, 58th Annual Meeting, Vascular Birthmarks: Diagnosis and Management for the Millennium, San Francisco, California, 03/11/2000 |
Guest Lecturer, Department of Genetics, "The Role of Pathology in Translational Research", Duke University, Durham, NC, 05/31/2000 |
Guest Lecturer, Department of Biology, "Hemangiogenesis: New Targets for Therapy", Massachusetts Institute of Technology, 06/05/2000 |
Guest Faculty, Second Annual CME Course on Vascular Anomalies (Speaker), "Unique Immunophenotypic Features of Juvenile Hemangioma: Implications for Pathogenesis." New York University, 05/18/2001 |
Grand Rounds Lecturer, "The Pathogenesis of Infantile Hemangioma." Massachusetts General Hospital, Department of Pathology, Boston, Massachusetts, 05/30/2001 |
Mega-Rounds Speaker, Department of Dermatology, Harvard University (Brigham and Women's Hospital), "Infantile Hemangioma: A Link to the Placenta", 02/06/2003 |
Symposium Speaker, American Academy of Dermatology, 61st Annual Meeting, Vascular Birthmarks Symposium, San Francisco, California, "The Histopathology of Vascular Birthmarks: Basic Criteria, Problem Areas, and Recent Advances, 03/22/2003 |
Workshop (CME) Director and Speaker (with Dr. Harry Kozakewich), Society for Pediatric Pathology, "Vascular Tumors and Malformations in Children", Washington, D.C., 03/23/2003 |
Invited Speaker, 2003 Port Wine Stain Conference, sponsored by the Vascular Birthmarks Foundation and the Skin Surgery Center of New York, "Port Wine Stains: Through the Looking Glass, New York University, New York, NY, 10/18/2003 |
Faculty, 6th Annual UAMS Anatomic Pathology Conference (CME), "Vascular Tumors and Malformations of Childhood: New Diagnostic Criteria, " Peabody Hotel, Little Rock, AR, 10/19/2003 |
Grand Rounds Speaker, Department of Pathology, University of California at Davis, Sacramento, CA, 12/11/2003 |
Grand Rounds Speaker, Department of Pathology, Stanford University, Palo Alto, California, 01/28/2004 |
Invited Speaker, "Vascular Tumors and Malformations - A View through the Looking Glass", Skåne University Hospital, Malmo, Sweden, 10/22/2004 |
Workshop (CME) Director and Speaker (with Dr. Harry Kozakewich), Society for Pediatric Pathology, "Vascular Tumors and Malformations in Children", San Antonio, TX, 02/27/2005 |
Plenary Session Lecturer, NIH-sponsored Hemangioma Research Workshop, "Histopathology and Molecular Phenotype", Bethesda, Maryland, 04/08/2005 |
Co-Chair and Speaker, Basic/Translational Research break-out session, NIH-sponsored Hemangioma Research Workshop, Bethesda, Maryland, 04/09/2005 |
Guest Faculty, Fourth Annual CME Course on Vascular Anomalies, New York University, "Evidence for Immune Tolerance in the Development of Infantile Hemangioma, New York, NY, 05/14/2005 |
Invited Speaker, "Unraveling the Mystery of Infantile Hemangioma - Recent Advances in Diagnosis and Research", American Society of Pediatric Otolaryngology Annual Meeting, 05/30/2005 |
Visiting Professor, Department of Pathology, Indiana University, 10/05/2005 |
Visiting Professor, Department of Cell Biology, Harvard Medical School, Boston, MA, 11/14/2005 |
Visiting Professor, Department of Pathology, Children's Hospital of Philadelphia, Philadelphia, PA, 01/09/2007 - 01/10/2007 |
Visiting Professor, Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, 01/23/2007 - 01/24/2007 |
Keynote Speaker, "Understanding Infantile Hemangioma: a Story of Discovery and Hope", Vascular Anomalies CME Course, New York University, New York, NY, 04/27/2007 |
Invited Speaker, Point-Counterpoint - Vascular Anomalies, New York University, New York, NY, 04/2007 |
Invited Speaker, "Vascular Tumors Associated with Coagulopathy", Haemangioma Vascular Malformations Center, Clinical & Integration Offsite Retreat, Cincinnati, OH, 12/14/2007 |
Invited Speaker, Vascular Anomalies Panel, American Society for Pediatric Otolaryngology Annual Meeting, Orlando, FL, 05/03/2008 |
Invited Speaker, "Vascular Malformations of the Head and Neck: a Biological Approach to Classification", American Society for Pediatric Otolaryngology Annual Meeting, Orlando, FL, 05/04/2008 |
Chair, Difficult Case Panel, International Society for the Study of Vascular Anomalies, 17th Annual Workshop, Boston, MA, 06/23/2008 |
Keynote Speaker, International Society for the Study of Vascular Anomalies, 17th Annual Workshop, Boston, MA "New Insights into Vascular Anomalies: a Pictorial Essay", 06/24/2008 |
Invited Speaker, "Molecular Mechanisms in the Pathogenesis of Venous Malformations", American Society for Pediatric Otolaryngology Annual Meeting, Seattle, WA, 05/22/2009 |
Invited Speaker, "The Life of an Endothelial Cell in Infantile Hemangioma", Children's Hospital of Philadelphia, Philadelphia, 07/2009 |
Invited Speaker, International Vascular Anomalies Symposium, University of Arkansas for Medical Sciences, 10/09/2009 |
Invited Moderator and Panelist, Pediatric Pathology Specialty Conference (CME) on Vascular Pathology, USCAP, 03/2010 |
Invited Speaker, Pathology Grand Rounds, University Hospitals Case Medical Center, Cleveland, Ohio, 04/14/2010 |
Invited Speaker, North Carolina Dermatological Society, University of North Carolina Hospitals, Asheville, NC, 08/07/2010 |
Invited Grand Rounds Speaker, Children's Memorial Hospital, Chicago, IL, 08/18/2010 |
Virginia H. and Russell McFarland Annual Lecturer in Pediatric Pathology, Texas Children's Hospital, Houston, TX, 01/21/2011 |
Invited participant and speaker, Lymphatic Malformations Consensus Meeting, Children's Hospital Boston, 02/05/2011 |
Invited Speaker, Society for Pediatric Pathology Fall Meeting, Research Update for Pathologists, "Vascular Anomalies - Recent Research Findings, New Investigational Tool, and Continuing Challenges", Milwaukee, WI, 10/01/2011 |
Invited Speaker, "Clinical Use of Whole Genome and Whole Exome Sequencing Today", College of American Pathologists, Whole Genome Sequencing Webinar, 12/11/2011 |
Invited Speaker, New York Academy of Sciences - Controversies in Vascular Anomalies, New York City, New York, 05/03/2013 - 05/04/2013 |
Invited Speaker, 1st International Conference on Generalized Lymphatic Anomaly and GorhamStout Syndrome, Bethesda, MD, 06/07/2013 - 06/08/2013 |
Invited Speaker, "Clinicopathological Correlation: Vascular...or Not?", 39th Annual Meeting of the Society for Pediatric Dermatology, Milwaukee, Wisconsin, 07/11/2013 - 07/14/2013 |
Invited speaker, Vascular Birthmarks Foundation 20th Anniversary Conference and Gala, New York, NY, 10/10/2014 - 10/11/2014 |
Invited Speaker and Panelist, Sturge-Weber Research Conference (NIH-funded), Bethesda, MD, 04/19/2015 - 04/20/2015 |
Invited Speaker and Panelist, Sturge-Weber Research Conference (NIH-funded), Bethesda, MD, 04/19/2015 - 04/20/2015 |
Invited Professorship in Vascular Anomalies, Texas A&M Health Science Center College of Medicine, 10/07/2015 - 10/08/2015 |
Inviter Speaker and Award Recipient (Physician of the Year) Vascular Birthmarks Foundation, San Diego, CA, 10/14/2015 |
Invited speaker, 2nd International Conference on Generalized Lymphatic Anomaly and GorhamStout Disease, Atlanta, GA, 06/10/2016 - 06/11/2016 |
Invited Lecturer and Tutor, Dermapedia Comprehensive Course (CME) on Soft Tissue Tumors (three lectures), San Diego, CA, 04/20/2017 - 04/22/2017 |
Inviter Faculty, "Cases and Controversies in Vascular Anomalies", at the New York Academy of Sciences, 7 World Trade Center, New York, NY, 05/05/2017 - 05/06/2017 |
Invited speaker, Association of Public Health Laboratories 2017 Annual Meeting, "Strengthening Laboratory System Partnerships -- Building Global Health Capacity Beyond Jurisdictions", Providence, Rhode Island, 06/14/2017 |
Invited Speaker and Tissue Banking Subgroup Leader, Sturge-Weber Foundation Clinical Care Network Conference, New Orleans, LA, 10/01/2017 - 10/02/2017 |
Regional |
Invited Speaker, Editor's Choice Pediatric Conference, sponsored by Children's Hospital of Wisconsin, Pfister Hotel, 06/01/2006 - 06/02/2006 |
Invited Speaker, Best Practices in Pediatrics - Winter 2007 Conference, Wilderness Resort, Wisconsin, 03/03/2007 |
Invited Speaker, "Exposure and Biological Analysis Core", Children's Environmental Health Sciences Core Center All Investigator Meeting, Milwaukee, 05/28/2013 |
Invited Speaker, "The Diagnostic Challenge of Pediatric Vascular Tumors and Malformations", University of Wisconsin - Madison, Department of Pathology Grand Rounds, Madison, WI, 02/06/2015 |
Local |
Guest Lecturer, Arkansas Society for Clinical Microbiology, "PCR in the Clinical Laboratory, 01/23/1997 |
Invited Speaker, Arkansas Cancer Research Center Research Forum, A Unique Microvascular Phenotype Shared by Infantile Hemangioma and Human Placenta: Implications for Pathogenesis, " Little Rock, AR, 02/04/2002 |
Research Rounds Speaker, Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, 02/14/2003 |
Invited Speaker, Pathology Research Rounds, University of Arkansas for Medical Sciences, 08/29/2003 |
Invited Speaker, Dean's Research Forum, University of Arkansas for Medical Sciences, 01/27/2004 |
Invited Speaker, "Precursor Cells, Homing Mechanisms, and Regression in Infantile Hemangioma - Lessons from the Placenta", Cardiovascular Research Institute Seminar Series, Medical College of Wisconsin, Milwaukee, Wisconsin, 11/16/2005 |
Invited Lecturer, Pediatric Surgery Multidisciplinary Research Seminar Series, Children's Hospital of Wisconsin, Milwaukee, Wisconsin, 01/16/2006 |
Invited Speaker, "Molecular Correlates of Proliferation and Involution in Infantile Hemangioma", Children's Research Institute Seminar Series, 11/03/2006 |
Invited Speaker, "Premature Endothelial Senescence in Infantile Hemangioma", Cardiovascular Research Institute, Medical College of Wisconsin, 11/15/2006 |
Invited Speaker, Children's Research Institute, 2007 Opening Research Symposium, Milwaukee, WI, 04/12/2007 |
Invited Speaker, "Multifocal Lymphangiomatosis with Thrombocytopenia", Professor's Rounds, Department of Pediatrics, Medical College of Wisconsin, 10/18/2007 |
Invited Speaker, "Vascular Anomalies: recent discoveries bring new hope", Vascular Anomalies Family Support Symposium, Milwaukee Zoo Conference Center (sponsored by Children's Hospital of Wisconsin), Milwaukee, WI, 10/26/2007 |
Invited Speaker (with Altheia Roquemore-Goins), "Pathology & Laboratory Medicine: 2008 - Changes for the Future", Leadership Forum, Children's Hospital of Wisconsin, 12/04/2008 |
Invited speaker, Interdisciplinary Workshop on Vascular Anomalies Associated with Coagulopathies, Crown Plaza, Milwaukee, WI, 10/06/2011 - 10/07/2011 |
Invited Speaker, "CRI Core-Facilitated Research", Children's Research Institute Noon Seminar Series, 10/05/2012 |
Invited Speaker, "Biobank Update", Midwest Athletes Against Childhood Cancer Advisory Committee Meeting, 12/04/2012 |
Invited Speaker, Milwaukee Mayor's Office, "The Children's Research Institute (CRI) Unexplained Infant Death Center: a multi-disciplinary interest group investigating the causes of infant mortality and sudden, unexplained infant death", 03/13/2013 |
Invited Speaker, "p16-Mediated Endothelial Cellular Senescence", Cancer Center Seminar Series, Medical College of Wisconsin, 03/14/2013 |
Invited Speaker (with Curtis Hedman), "Evaluation of Environmental Health in Developing Rural Peru: novel translational approaches", Zilber School of Public Health, 03/24/2015 |
PEER REVIEWED WORKSHOPS/PRESENTATIONS: |
International |
G Shafirstein, T Waner, A Mizeracki, CH Hemphill, M Waner, PE North. Living Pig Skin as a Model for Study of Laser-Tissue Interactions in Port-Wine Stain (PWS). Mod Pathol 17(S1): 98A, 2004. |
North PE, DeAos I, Lal A, Riggins G, Marchuk DA, Waner M, and Mihm MC. High Expression of Indoleamine 2, 3 Deoxygenase in Infantile Hemangioma. Mod Pathol 17(S1): 97A, 2004. |
Mukunyadzi P, Zhang F, Fan C-Y, North PE. Utility of GLUT1 Expression in Distinguishing Renal Cell Carcinoma from Adrenal Tumors. United States and Canadian Academy of Pathology, 2005 Annual Meeting, San Antonio, TX Mod Pathol 2005. |
Scherer K, Onodera H, DeAos I, Waner M, Buckmiller L, Mihm MC, and North PE. Cellular Senescence and p16 expression in Infantile Hemangioma. 2006 Society for Pediatric Pathology Annual Meeting, Atlanta, GA. |
Maronn M, Catrine K, North PE, et al. Multifocal Lymphangioendotheliomatosis with Thrombocytopenia:expanding the phenotype. International Society for the Study of Vascular Anomalies 17th Congress, Boston, MA, June 21-24, 2008. |
Kumar S, DeAos I, Mihm MC, and North PE. Markedly Elevated Kynurenine/Tryptophan Ratio in Proliferative Phase Infantile Hemangioma: Potential Neurological Implications. International Society for the Study of Vascular Anomalies 17th Congress, Boston, MA, June 21-24, 2008. |
Salato V, Wang FW, Kumar S, and North PE. Selective High Expression of the Mesenchymal Homeobox Gene MEOX2 in Endothelial Cells of Infantile Hemangioma and Placenta. International Society for the Study of Vascular Anomalies 17th Congress, Boston, MA, June 21-24, 2008. |
Szabo S, Drolet B, Jensen J, and North PE. Early Regressive and Abnormally Persistent Infantile Hemangiomas: Learning from the Extremes. International Society for the Study of Vascular Anomalies 17th Congress, Boston, MA, June 21-24, 2008. |
Yang Q, Salato V, Szabo S, Kumar S, Wang FW, Wimpee B, and North PE. A New Ultra-thin Organotypic Slice Model of Infantile Hemangioma (IH) with Sustained Viability and Preserved Endothelial Cell (EC) Phenotype. International Society for the Study of Vascular Anomalies 17th Congress, Boston, MA, June 21-24, 2008. |
Sieber F, Muir SA, Cohen EP, North PE, Fish BL, Irving AA, Mader M, Moulder JE. High-dose selenium for the mitigation of radiation injury: a pilot study in a rat model. 54th Annual Meeting of the Radiation Research Society, Boston, MA, September 21-24, 2008. |
Wilcox DA, Fang J, North P, Nurden P, Nurden AT, Valentin N. High Mortality in Mice with |
Platelets Expressing Integrin αIIbβ3 Locked-In Its High Affinity State. American Society of Hematology Annual Meeting, San Francisco CA, Dec 6, 2008. |
Szabo S, Heaton C, Wimpee B, and North PE. Differential Expression of Infantile Hemangioma |
(IH)-Associated Antigens along the Normal Placental Vascular Tree and in Placental Chorangiomas. 18th Congress, International Society for the Study of Vascular Anomalies, Brussels, Belgium, April 22, 2010. |
Sander T, Noll L, Zembles T, Salato V, Webb A, Kumar S, and North PE. Detection of CYP2C19 |
Single Nucleotide Polymorphisms in Patients with Infantile Hemangioma that Predict Reduced Metabolism of Propranolol, 18th Congress, International Society for the Study of Vascular Anomalies, Brussels, Belgium, April 22, 2010. |
Yang Q, Kumar S, Salato V, Szabo S, and North PE. Propranolol inhibits proliferation and tube formation by purified placental capillary endothelial cells, an in vitro model for infantile hemangioma (IH), and induces their apoptosis. 18th Congress, International Society for the Study of Vascular Anomalies, Brussels, Belgium, April 22, 2010. |
Miao Q, North PE et al. Nogo-B Receptor Is Essential for Angiogenesis in Vivo via Akt Pathway, American Heart Association Scientific Sessions, Nov 2010, Chicago, IL(selected as one of the top 10% AHA specialty conference abstracts, 2010). |
Weber D, Brosig C, Kumar S, Lerch-Gaggl A, Leigh N, Chun CZ, North P, Peterson T, |
Ramchandran R. Linking Congenital Cardiovascular Malformations to Neurobehavioral Outcomes in a Zebrafish Model: Preliminary Studies. 4th Annual Pediatric Behavioral Health Research Conference: Building and Sustaining Research Teams, Milwaukee, WI, February 25, 2011. |
Worthey E, Taylor B, Jacob H, Schauer D, North P, Sander T, McQuestion G, Bick D, Dimmock D. Experience with the analysis and management of data from whole genome sequencing in clinical practice, Annual Meeting of the American College of Medical Genetics, March 18, 2011. |
Sander T, Wong S, North PE. Pharmacogenetics testing for forensic pathology paves the way for "Personalized Justice" American Society of Investigational Pathology, Washington, DC, April 11, 2011. |
Kwon E-K, Siegel DH, Broeckel U, North PE, Worthey E, Chiu YE and Drolet BA. Functional analysis of candidate genes identified by genomewide association study (GWAS) of infantile hemangiomas (IH), Annual meeting of the Society for Investigational Dermatology, May, 2011. |
Salato V, Yang Q, Scherer K, Wimpee B, Onodera H, Waner M, Tetzlaff J, and North PE. p16INK4a mediated endothelial cell senescence is a fundamental mechanism of spontaneous involution in infantile hemangioma. 19th Congress, International Society for the Study of Vascular Anomalies, Malmo, Sweden, June, 2012. |
Lerch-Gaggl A and North PE. Not Just a Repository - The CRI Pediatric BioBank & Analytical |
Tissue Core: Making an Impact on Research Studies by Offering Analytical Services to Investigators. 2012 Intl Society for Biological & Environmental Repositories Annual Meeting, Vancouver, British Columbia, Canada. |
Yang Q, Kumar S, Salato V, Szabo S and North PE. Propranolol Blocks Autophagy in Infantile Hemangioma (IH) and Human Placental Capillary Endothelial Cells (HPCECs) in vitro, 19th Congress, International Society for the Study of Vascular Anomalies, Malmo, Sweden, June, 2012. |
Subramanian S, Chun R, North P, Moe D, Kelly T. Rare submandibular bronchopulmonary foregut cystic malformation mimicking lymphatic malformation. American Society of Neuroradiology Annual meeting, May 18, 2013. |
North PE. Histopathology of diffuse lymphatic malformation and Gorham's disease. First |
International Conference on Generalized Lymphatic Anomaly and Gorham-Stout Syndrome |
Bethesda, Maryland, June 6, 2013. |
Runge C, Sander T, Dimmock D, North PE, Lerch-Gaggl A, Friedland D, Kershner J. Development of a Genetic Newborn Hearing Screen Platform, American Society of Pediatric Otolaryngology Annual Meeting, May, 2014. |
Bachur C, Sachdev M, Connors S, Curatolo A, Shotwell L, North P, Marchuk D, Pevsner J, Moses M, Comi AM. Increased p-ERK expression in leptomeningeal vessels of Sturge Weber syndrome. 20th Congress, International Society for the Study of Vascular Anomalies, Melbourne, Australia, Australia, April 2, 2014. |
Salato V, Yang Q, Comi A, Pevsner J, Gredler J, Gallione C, Marchuk D, and North PE. Identification of Cell Types Harboring GNAQ mutation in Port Wine Stain Tissue. 20th Congress, International Society for the Study of Vascular Anomalies, Melbourne, Australia, April 2, 2014. |
Sander T, Mitchell A, Mitchell M, Noll L, Mahnke D, Routes J, and North P. Implementation of a Highly-Sensitive and Inexpensive Laboratory Developed Test for 22q11.2 Deletion Syndrome, Association for Molecular Pathology 2015 Meeting, Austin, TX, Nov 3, 2015. |
Hartman H and North PE. Peak Flow Measurement and Environmental Exposure Analysis in Rural Peru. American Academy of Allergy, Asthma, and Immunology Annual Meeting, March 4, 2016. |
Alan J. Bergmann, Luis Vasquez, Paula E North, Kim A. Anderson, Passive Sampling in the Alto Mayo, Society of Environmental Toxicology and Chemistry Annual Meeting November, 2016. |
Buenos Aires, Argentina, April 27, 2016. |
Schwalbe ML, Mrak LN, Gill KG, Pinchot JW, Aagaard- Kienitz BL, Moe D, King D, Buehler |
D |
Malformation of the Extremity (Fibro-Adipose Vascular Anomaly): a Clinicopathologic Study of 23 Cases. 21st Congress, International Society for the Study of Vascular Anomalies, Buenos Aires, Argentina, April 27, 2016. |
Martinez AP, Zapata M, North PE, Folpe AL, Weiss SW. Lymphatic-type Angiosarcoma (AS) with a Prominent Lymphocytic Infiltrate: A Potentially More Favorable Subgroup? United States and Canadian Academy of Pathology, 2018 Annual Meeting, Vancouver, British Columbia, Canada, March 2018. |
Mrak LN, Woods MA, Diamond AC, Pinchot JW, Aagaard Kienitz B, Arkin LM, North PE, Buehler DG, Gill KG. 21st Congress, International Society for the Study of Vascular Anomalies, Amsterdam, the Netherlands, May, 2018. |
North PE and Salato V, Lobular Capillary-Lymphatic Malformation of Subcutis: a Newly Recognized Entity with Distinctive Histological and Clinical Features, 21st Congress, International Society for the Study of Vascular Anomalies, Amsterdam, the Netherlands, May, 2018. |
North PE, Ziegler A, Mitchell A, et al. Highly Sensitive Multiplex PCR Assessment of cfDNA Donor Fraction in Pediatric and Adult Heart Transplant Patients: Non-Invasive Risk Stratification for Rejection in an Expanded Patient Population and Post-Transplantation, Cutting Edge of Transplantation Summit 2019, American Society of Transplantation, Phoenix, Arizona, Feb 2019. |
Peterson B, Tlomak W, Noll L, North P, Sander T. Use of Pharmacogenetics as an aid in discerning manner of death in oxycodone intoxication. National Association of Medical Examiner's Annual Meeting, Oct 15, 2013. |
North P, Fleischer S: The effect of increased membrane cholesterol content on rat brain synaptosomes. Soc Neurosci Abstr 5:1014, 1979. |
North P, Fleischer S: Reversible loss of high-affinity, sodium-dependent gamma-aminobutyric acid uptake of synaptic plasma membranes depleted of cholesterol. Soc Neurosci Abstr 7:306, 1981. |
North PE, Post RL: Two patterns of inhibition of (Na, K) ATPase by vanadyl ion. Fed Proc 42:1926, 1983. |
North PE, Mrak RE: Synaptic membrane transport of choline and of gamma aminobutyric acid (GABA): Effects of ethanol and other n-alcohols. Neurotoxicology 9:689, 1988. |
Sawyer JR, Swanson CM, Lukcas JL, Nicholas R, North PE, and Thomas JR: Complex translocations involving 6q13 and chromosomal instability in histologically benign, but locally |
aggressive cartilaginous lesions. Amer. Soc. Human Genetics Abstr, 1996. |
Dornhoffer JL, Colvin GB, North P: Microscopical examination of ossicles in patients with cholesteatoma. Proceedings of the Fifth International Conference on Cholesteatoma and Mastoid Surgery, Sardinia, Italy, 1996. |
Sawyer JR, Swanson CM, Lukacs JL, Nicholas RW, North PE, and Thomas, JR: Recurring chromosome breakpoints at 6q13-21 in histologically benign, but locally aggressive cartilaginous lesions. Seventh International Workshop on Chromosomes and Solid Tumors, 1997. |
Colby S, Chapman YL, Luo Y, Mitsuhashi M, Moorthy TV, Zoha S, Allnut T, Mizeracki A, North P, Musk P, Eisenberg A, and Smead D: Use of the FMBIO II Imaging System in Diagnostic Assays. Assoc. For Molec. Pathol. Abstr., 1998. |
Colby S, Chapman W, Luo Y, Mitsuhashi M, Moorthy TV, Allnut T, North P, Musk P, and Smead D: Using fluorescence detection in molecular diagnostic applications. DNA Technologies in Human Disease Detection Conf. Abstr, 1998. |
North PE, Waner MW, Mizeracki A, and Mihm MC, Jr: GLUT1 is a specific marker for juvenile hemangiomas. 1999 Annual Meeting United States and Canadian Academy of Pathology. March 2026, 1999. San Francisco, California. |
Parham DM, Quiggins C, Ready R, and North PE, Comparison of manual vs. automated leukocyte counts for determination of the absolute neutrophil count. Joint Annual Meeting of the International Society of Paediatric Oncology and the American Societ, Montreal, Canada, 1999. |
North PE, Waner MW, Mizeracki A, and Mihm MC, Jr.: Unique coexpression of |
GLUT1, merosin, and Lewis Y antigen by juvenile hemangiomas at all stages. 2000 Annual Meeting United States and Canadian Academy of Pathology. |
North PE, Mizeracki A, Thomas JR, Nicholas R, Waner MW, and Mihm MC, |
Jr.: Intramuscular "hemangiomas" are vascular malformations immunodistinct from juvenile hemangiomas. 2000 Annual Meeting United States and Canadian Academy of Pathology. Lab Invest 80:14A, 2000. |
North PE, Mizeracki A, Waner M, Mihm MC, Jr., and Mrak RE: Do juvenile hemangiomas originate from endoneurial microvasculature? 2000 Annual Meeting of the American Association of Neuropathologists. |
North PE and Mihm MC, Jr.: Pathology of juvenile hemangiomas and vascular malformations. 2000 Annual Meeting of the American Academy of Dermatology, San Francisco, CA, 2000. |
North PE: Frontiers of research in vascular birthmarks. 2000 Annual Meeting of the American Academy of Dermatology, San Francisco, CA, 2000. |
Brown H, Mizeracki A, Mrak RE, and North PE: Glucose transporter isoform 1 in neovascularized |
ocular tissue. Assoc. for Research in Vision and Ophthalmology Abstracts, Fort Lauderdale, FL, 2000. |
Walter JW, North PE, Mizeracki A, Waner M, and Marchuk DA: Non-random X-inactivation suggests that juvenile hemangiomas are monoclonally derived. 2000 Annual Meeting of the American Society of Human Genetics, Philadelphia, PA. |
North PE, Mizeracki A, Mihm MC, Jr., and Mrak RE.: GLUT1 immunoreaction patterns reliably distinguish hemangioblastoma from metastatic renal cell carcinoma. 2000 Annual Meeting United States and Canadian Academy of Pathology. |
North PE and Mihm, MC, Jr.: Juvenile hemangiomas share a unique immunophenotype with the microvasculature of placenta: implications for pathogenesis.13th Congress, International Society for the Study of Vascular Anomalies, Montreal, Canada, 2000. |
Waner M, Waner A, North P, Mihm MC, Jr., Sigfried I, and Suen JY: Identification of two distinct types of hemangiomas. 13th Congress, International Society for the Study of Vascular Anomalies, Montreal, Canada, 2000. |
Waner M, Adams D, North P, and Yee S: A rare complication of pulsed dye laser treatment of hemangiomas. 13th Congress, International Society for the Study of Vascular Anomalies, Montreal, Canada, 2000. |
North PE, Waner MW, Mizeracki A, Mihm MC, Jr.: Diffuse (dermatomal) and focal juvenile hemangiomas are histologically and immunophenotypically similar Mod Pathol; 14(1): 71A, 2001. |
North PE, Waner MW, Mizeracki A, Nicholas R, Kincannon J, Gibson D, and Mihm MC, Jr: Placental antigens expressed by juvenile hemangiomas are not present in other benign vascular proliferations Mod Pathol; 14(1):71A, 2001. |
Nicholas RW, Thomas JR, Mizeracki A, Waner M, James CJ, Mihm MC, Jr, and North PE. Are intramuscular vascular malformations truly "hemangiomas?" Musculoskeletal Tumor Society Annual Meeting, May 2001. |
Walter J, North PE, Mizeracki A, Waner M, and Marchuk D. Somatic mutations in sporadic hemangiomas. Amer J Human Genet., 68, 2001. |
North PE, Waner MW, Mizeracki A, Mihm MC, Jr.: Diffuse (dermatomal) and focal juvenile hemangiomas are histologically and immunophenotypically similar Mod Pathol; 14(1): 71A, 2001. |
North PE, Waner MW, Mizeracki A, Nicholas R, Kincannon J, Gibson D, and Mihm MC, Jr: Placental antigens expressed by juvenile hemangiomas are not present in other benign vascular proliferations Mod Pathol; 14(1):71A, 2001. |
Walter J, North PE, Mizeracki A, Waner M, and Marchuk D. Somatic mutations in sporadic hemangiomas. Amer J Human Genet., 68, 2001. |
Nicholas RW, Thomas JR, Mizeracki A, Waner M, James CJ, Mihm MC, Jr, and North PE. Are intramuscular vascular malformations truly "hemangiomas?" Musculoskeletal Tumor Society Annual Meeting, May 2001. |
North PE, Frieden IJ, McCalmont T, Mizeracki A, Detmar M, and Mihm MC. The morphological spectrum of tufted angioma and kaposiform hemangioendothelioma: a lymphothelial association with coagulopathy. 14th Congress, International Society for the Study of Vascular Anomalies, Nijmegen, the Netherlands, June 27, 2002. |
DeAos I, Mizeracki A, Waner M, and North PE. Infantile hemangiomas are immunonegative for estrogen (alpha and beta) and progesterone receptors: reassessment of previous assumptions. 14th Congress, International Society for the Study of Vascular Anomalies, Nijmegen, the Netherlands, June 27, 2002. |
Mizeracki A, Waner M, Davis PF, and North PE. Histological and immunohistochemical analysis of hemangiogenesis in fibrin gels: pericytes first, endothelial cells second. 14th Congress, International Society for the Study of Vascular Anomalies, Nijmegen, the Netherlands, June 27, 2002. |
Frieden IJ, Kahn K, Cordisco M, and North PE. Multifocal angioendotheliomatosis with coagulopathy. 14th Congress, International Society for the Study of Vascular Anomalies, Nijmegen, the Netherlands, June 27, 2002. |
James CA, North PE, Nicholas R, and Waner M. Mass lesions in soft tissue arteriovenous malformations: radiologic/pathologic correlation. 14th Congress, International Society for the Study of Vascular Anomalies, Nijmegen, the Netherlands, June 27, 2002. |
North PE, Frieden IJ, Kincannon J, and Mihm MC. Multiple congenital pyogenic granuloma-like proliferations mimicking diffuse hemangiomatosis: a prototypic case study. 14th Congress, International Society for the Study of Vascular Anomalies, Nijmegen, the Netherlands, June 27, 2002. |
Sanchez-Carpintero I, North PE, Waner M, Mihm MC. The heterogeneity of cutaneous vascular stains: a clinicopathological study. 14th Congress, International Society for the Study of Vascular Anomalies, Nijmegen, the Netherlands, June 27, 2002. |
Frieden IJ, Waner M, McCalmont T, and North PE. The histologic spectrum of hemangioma of infancy, 14th Congress, International Society for the Study of Vascular Anomalies, Nijmegen, the Netherlands, June 26, 2002. |
Shafirstein G, Mizeracki A, North PE, and Waner M. Vascular structure in corrosion casts of arteriovenous malformations (AVMSs), venous malformations (VMs), and hemangiomas. 14th Congress, International Society for the Study of Vascular Anomalies, Nijmegen, the Netherlands, June 27, 2002. |
North PE, Sanchez-Carpintero I, Waner M, Mizeracki A and Mihm MC. Despite striking clinical dissimilarities segmental and focal infantile hemangiomas are histologically and immunohistochemically identical, 20th World Congress of Dermatology, Paris, France, July 2002. |
Sanchez-Carpintero I, Martinez MI, North PE, Waner M, and Mihm MC. Imiquimod: remarkable therapy for vascular lesions, 20th World Congress of Dermatology, Paris France, July 2002. |
Frieden IJ, Kahn K, Cordisco M, and North PE. Multifocal angioendotheliomatosis with coagulopathy (oral presentation). 14th Congress, International Society for the Study of Vascular Anomalies, Nijmegen, the Netherlands, June 26, 2002. |
North PE, Frieden IJ, McCalmont T, Mizeracki A, Detmar M, and Mihm MC. The morphological spectrum of tufted angioma and kaposiform hemangioendothelioma: a lymphothelial association with coagulopathy. 14th Congress, International Society for the Study of Vascular Anomalies, Nijmegen, the Netherlands, June 26, 2002. |
DeAos I, Mizeracki A, Waner M, and North PE. Infantile hemangiomas are immunonegative for estrogen (alpha and beta) and progesterone receptors: reassessment of previous assumptions. 14th Congress, International Society for the Study of Vascular Anomalies, Nijmegen, the Netherlands, June 26, 2002. |
Mathew S, Parham DM, Ready R, Quiggins C, Jacobs RF, Maes L, North PE. High interlaboratory variability in pediatric band counts. Mod Pathol 2002; 15(1):254A. February, 2002. |
Tyler LN, Parham DP, Glasier CM, Mrak RE, Mizeracki A, Burson GT, and North PE. |
Immunostaining of focal cortical dysplasia with MIB1 and anti-p53. Mod Pathol; 15(1):6P, 2002. |
North PE, Waner M, James CA, Mizeracki A, and Mihm MC, Jr. Congenital nonprogressive hemangioma: a distinct clinicopathological entity unlike infantile hemangioma. Mod Pathol; 15(1):104A, 2002. |
North PE, Mizeracki A, Waner M, and Davis P. Ex vivo hemangiogenesis in fibrin gels: a morphological and immunohistochemical analysis. Lab Invest 83(1):18A, 2003. |
Lyons LL, North PE, Stoler MH, Folpe AL, Weiss SW. Kaposiform hemangioendothelioma (KH) is histologically, immunohistochemically, and biologically distinct from common (juvenile) hemangioma. Lab Invest 83(1):16A, 2003. |
North PE, Sanchez-Carpintero I, Mizeracki A, Waner M, and Mihm MC. The distinctive histology of lip enlargement in port-wine stains: a clinicopathological study. Lab Invest 83(1):96A, 2003. |
DeAos I, Mizeracki A, Mihm MC, and North PE. Infantile hemangiomas are immunonegative for estrogen (alpha and beta) and progesterone (A/B) receptors: reassessment of previous assumptions. Lab Invest 83(1):90A, 2003. |
DeAos I, Frieden IJ, Kahn T, Cordisco M, Detmar M, and North PE. Multifocal papillary angiomatosis with thrombocytopenia: a new clinicopathological entity. Mod Pathol 16:2p, 2003. |
North PE, DeAos I, Lal A, Riggins G, Marchuk DA, Waner M, and Mihm MC. Immune Tolerance in Infantile Hemangioma. 15th Congress, International Society for the Study of Vascular Anomalies, Wellington, New Zealand, February 23, 2004. |
North PE, DeAos I, Hemphill CH, Waner M, Mihm MC. A Mechanism of Skin Homing in Infantile Hemangioma. 15th Congress, International Society for the Study of Vascular Anomalies, Wellington, New Zealand, February 23, 2004. |
DeAos I, James CA, and North PE. Hepatic "hemangioma": not a singular entity. 15th Congress, International Society for the Study of Vascular Anomalies, Wellington, New Zealand, February 23, 2004. |
North PE, DeAos I, Hemphill CH, Waner M, Mihm MC. D2-40 antibody: limited utility in the diagnosis of kaposiform hemangioendothelioma. 15th Congress, International Society for the Study of Vascular Anomalies, Wellington, New Zealand, February 23, 2004. |
North PE, DeAos I, Hemphill CH, Waner M, MC Mihm. Marked differences in the lymphatic compliments of cutaneous infantile and congenital hemangioma. 15th Congress, International Society for the Study of Vascular Anomalies, Wellington, New Zealand, February 23, 2004. |
Prendiville JS, Brown K, Davis J, DeSa D, Jamieson D, North P. Skeletal-extraskeletal angiomatosis in a child. 15th Congress, International Society for the Study of Vascular Anomalies, Wellington, New Zealand, February 23, 2004. |
Shafirstein G, Baumler W, Lapidoth M, North PE, Waner M. Mathematical modeling to suggest optimal FPDL pulse time and wavelengths to treat PWS. 15th Congress, International Society for the Study of Vascular Anomalies, Wellington, New Zealand, February 23, 2004. |
North PE, DeAos I, Hemphill CH, Waner M, Mihm MC. CCR6 Expression by Endothelial Cells of Infantile Hemanigioma. Society for Pediatric Pathology Annual Meeting, Vancouver, British Columbia, March 6, 2004. |
Ferguson PE, Oza KK, Ellison DA, North PE, Horn H. Color-matched cassettes and slides decrease specimen handling errors. Mod Pathol 17(S1): 347A, 2004. |
Dadras SS, North PE, Bertoncini J, Jackson DG, Mihm MC, and Detmar M. LYVE-1, a novel lymphatic endothelial cell marker, is expressed in infantile hemangiomas. Mod Pathol; 17 (S1):12A, 2004. |
COMMITTEE SERVICE: |
Medical College of Wisconsin |
1990 - 92 Curriculum Committee, University of Arkansas for Medical Sciences |
1990 - 92 Search Committee for Microbiology and Immunology Chair, University of Arkansas for Medical Sciences |
1996 - Present Faculty Incentive Plan Committee, Department of Pathology, University of Arkansas for Medical Sciences, School of Medicine |
1996 - 2000 Promotions Committee, Class of 2000, University of Arkansas for Medical Sciences, School of Medicine |
1998 - 2005 Residency Committee, Department of Pathology, University of Arkansas for Medical Sciences |
2001 - 2005 MD/PhD Committee, University of Arkansas for Medical Sciences, School of Medicine |
2006 - 2010 Scientific and Policy Advisory Committee, Children's Research Institute, Children's Hospital Health System and Medical College of Wisconsin |
2006 - 2008 Dermatology Chair Search Committee, Medical College of Wisconsin |
2007 - 2006 Search Committee for Chief Medical Officer and SVP, Blood Center of Wisconsin |
2010 - 2011 Search Committees, Pediatric Hematology/Oncology Section Chief and MACC Fund Professor, Medical College of Wisconsin |
2010 - 2014 Post-doctoral Training Program Steering Committee, Children's Research Institute |
2011 - Present Search Committee, Children's Specialty Group CEO, Medical College of Wisconsin |
2012 - 2013 Rank and Tenure Committee, Medical College of Wisconsin |
2015 - 16 Search Committee, Department of Dermatology, Medical College of Wisconsin. |
2015 - 2017 Search Committee, Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin. |
Hospital |
1995 - 97 Transfusion Committee, Arkansas Children's Hospital |
1996 - 2003 Point-of-Care Testing Committee, Arkansas Children's Hospital |
1998 - 2004 Radiation Safety and Use Committee, Arkansas Children's Hospital |
2002 - 2003 Transfusion Committee, Arkansas Children's Hospital |
2002 - 2005 Phlebotomy Subcommittee (Chair), Patient Care Committee, Arkansas Children's Hospital |
2003 - 2005 Medical Leadership Committee, Arkansas Children's Hospital |
2003 - 2005 Member and Officer (Secretary-Treasurer, 2003-2004)/(Vice President, 2005), Medical Executive Committee, Arkansas Children's Hospital |
2004 - 2005 Physicians Health Subcommittee, Arkansas Children's Hospital |
2005 - Present Clinical Laboratory Executive Committee, Children's Hospital of Wisconsin |
2005 - 2014 Operating Room Committee, Children's Hospital of Wisconsin |
2005 - Present Medical Executive Committee, Children's Hospital of Wisconsin |
2006 - Present Joint Patient Care Committee, Children's Hospital of Wisconsin |
2006 - 2014 Physician's Quality Assurance Committee, Children's Hospital of Wisconsin |
2006 - 2014 Council for Quality, Children's Hospital of Wisconsin |
2006 - Present Action Sub-Committee, Medical Staff Executive Committee, Children's Hospital of Wisconsin |
2006 - Present Credentials Committee, Children's Hospital of Wisconsin Medical Staff |
2006 - 2012 Patient Care Safety Committee, Children's Hospital of Wisconsin |
2006 - 2014 Medical Capital Equipment Committee, Children's Hospital of Wisconsin |
2010 - 2014 Surgical Services Executive Committee, Children's Hospital of Wisconsin |
2010 - 2014 Operations Executive Committee, Children's Hospital of Wisconsin |
2011 - 2013 iStrategy Executive Steering Committee, Children's Hospital of Wisconsin |
2012 - 2014 Quality Improvement Executive Committee, Children's Hospital of Wisconsin |
MCW TEACHING ACTIVITIES: |
Medical Student Education |
Medical Student Summer Research Mentor, Medical College of Wisconsin, 2006 and 2009. |
Lecturer, "Vascular Tumors and Malformations", M2 Pathophysiology Course, Medical College of Wisconsin, 12/03/2009. |
Lecturer (1 lecture annually), Vascular Pathology, Sophomore Pathophysiology Course, University of Arkansas for Medical Sciences, Medical School, 11/2003 - 11/2006. |
Section Leader (5 lectures annually), Gastrointestinal Pathology, Sophomore Pathophysiology Course, University of Arkansas for Medical Sciences, Medical School, 09/1995 - 05/2001. |
Pathway Advisor, Physician Scientist Pathway, Medical College of Wisconsin, 2009 and 2014-2017. |
Pathway Advisor, Global Health Pathway, Medical College of Wisconsin, 2012-2016. |
Resident and Fellow Education |
Residency Director, Pediatric Pathology, Children's Hospital of Wisconsin, 09/2005 - 2008. |
Lecturer, "Vascular Tumors and Malformations of Childhood: a clinicopathological approach to diagnosis and treatment", Pediatric Surgery Resident Didactic Series, Children's Hospital of Wisconsin, 01/06/2006. |
Lecturer, "Current Classification of Hepatic Vascular Lesions", Pediatric Surgery Residents, 08/16/2006. |
Invited Lecturer, Hematology-Oncology Fellowship Lecture Series, Children's Hospital of Wisconsin, Milwaukee, Wisconsin, 04/26/2006. |
Lecturer, "Vascular Tumors", Resident Lecturer Series, Department of Pathology, Medical College of Wisconsin, 01/08/2007. |
Lecturer, "Vascular Malformations", Resident Lecturer Series, Department of Pathology, Medical College of Wisconsin, 01/09/2007. |
Lecturer, "Vascular Malformations: a current clinicopathological approach to diagnosis and classification, Resident Didactic, Department of Otolaryngology/Head & Neck Surgery, Medical College of Wisconsin, 03/19/2009. |
Invited Lecturer, "Finding the Genetic Cause of Venulo-Capillary Malformation: a needle in the haystack", Pediatric Surgery Resident Didactic Series, Medical College of Wisconsin, 02/14/2014. |
Fellowship Director, Pediatric Pathology, Children's Hospital of Wisconsin, 09/2012 - 05/2015. |
Director, Pediatric Molecular Pathology Rotation, University of Arkansas for Medical Sciences, 07/1999 - 06/2002. |
Director, Pediatric Clinical Pathology Resident Rotation, University of Arkansas for Medical Sciences, Medical School, 07/1998 - 06/2003. |
EXTRAMURAL TEACHING: |
Resident and Fellow Education |
05/14/2005 - Present Guest Faculty, Fourth Annual CME Course on Vascular Anomalies, New York University, New York, NY. |
10/05/2005 - Present Visiting Professor, Department of Pathology, Indiana University. |
11/14/2005 - Present Visiting Professor, Department of Cell Biology, Harvard Medical School, Boston, MA. |
01/23/2007 - 01/24/2007 Visiting Professor, Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX. |
11/09/2007 - 11/10/2007 Visiting Professor, Department of Pathology, Children's Hospital of Philadelphia, Philadelphia, PA. |
06/16/2012 - Present Faculty, 19th International Workshop on Vascular Anomalies, International Society for the Study of Vascular Anomalies, Basic Course, "Histopathology of Vascular Anomalies for Pathologists", Malmo, Sweden. |
09/15/2012 - 09/21/2012 Invited Tutor, International Paediatric Pathology Association XXXIVth Advanced Course in Paediatric Pathology (multiple lectures over 1 week period), La Granja, Spain. |
03/31/2014 - Present Organizing Moderator and Keynote Speaker, day-long International Workshop for Pathologists - "The Pathology of Vascular Lesions", Royal Children's Hospital, Melbourne, Australia. |
04/12/2014 - 04/14/2014 Guest Faculty, Workshop on the Classification of Vascular Anomalies, XIVth Scientific Meeting of the Eastern China Cooperative Group of Pediatric Pathologists, Shanghai, China, April 12-14, 2014. |
05/28/2015 - Present Invited Tutor, Workshop for Pathologists (at multi-headed microscope), Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. |
11/22/2015 - 11/27/2015 Invited Tutor, International Paediatric Pathology Association Update Pediatric Pathology Course, Margaret River, Australia. |
03/08/2016 - Present Faculty and Keynote Speaker, EADV Fostering Course in Vascular Anomalies, Malmö, Sweden. |
05/31/2018 - Present Faculty and Moderator, Day-long International Course on the Histopathologic and Molecular Diagnosis of Vascular Anomalies, Amsterdam, The Netherlands (scheduled) in conjunction with the 22nd International Workshop of the International Society for the Study of Vascular Anomalies. |
MCW STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOWS MENTORED: |
Medical Students |
2012 - 2014 Katie Dobberpuhl, 2012 - 2014, MCW, Global Health Pathway Student: Pathway adviser. |
EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED: |
Medical Students |
Graduate Students |
PhD Committees |
10/2016 - Present Zachary Brandt, current., MCW (Cell Biology) |
Clinical/Research Fellows |
Residents |
Faculty |
06/2014 - Present Darya Buehler, 06/2014 - current, MD (UW-Madison Pathology), Capacity: clinical and research mentor (vascular anomalies). |
PROGRAMMATIC DEVELOPMENTS: |
Educational Programs |
Fellow |
2013 - Present Pediatric Pathology Fellowship Program (new fellowship, ACGME) |
Research Programs |
2012 - Present Unexplained Infant Death Focus Group, Children's Research Institute |
2012 - 2015 GEOHEALTH research program (NIEHS), Alto Mayo, Peru |
Children's Environmental Health Sciences Core Center, Milwaukee, WI (multi-institutional) |
COMMUNITY SERVICE ACTIVITIES: |
Board member, Get Fit Foundation, Milwaukee, WI, 2013 - present. |
Local organizing committee, USA Triathlon National Age Group Championships, 2013 and 2014, Milwaukee, WI |
BIBLIOGRAPHY |
Refereed Journal Publications/Original Papers |
1. North P, Fleischer S: Alteration of synaptic membrane cholesterol/phospholipid ratio using a lipid transfer protein. Effect on gamma-aminobutyric acid uptake. J Biol Chem 258:12421253, 1983. |
2. North P, Fleischer S: The use of a nonspecific lipid transfer protein to modify the cholesterol content of synaptic plasma membranes. Methods in Enzymol 98:599-613, 1983. |
3. North P, Fleischer S: Protein-mediated exchange of synthetic phosphatidylcholines into synaptosomal membranes. Biochim Biophys Acta 772:65-76, 1984. |
4. North P, Post RL: Inhibition of (Na,K) ATPase by tetravalent vanadium. J Biol Chem 259:4971-4978, 1984. |
5. Mrak RE, North PE: Ethanol inhibition of synaptosomal high-affinity choline uptake. Eur J Pharmacol 151:51-58, 1988. |
6. North PE, Mrak RE: Synaptosomal uptake of choline and of gamma-aminobutyric acid: Effects of ethanol and of dimethylsulfoxide. Neurotoxicology 10:569-576, 1989. |
7. Mrak RE, North PE: Triphasic effects of short chain n-alcohols on synaptic membrane transport of choline and of gamma-aminobutyric acid. Biochim Biophys Acta 984:97-103, 1989. |
8. Wheeler RR, Bardales RH, North PE, Vesole DH, Tricot G, Stanley MW: Toxoplasma pneumonia: cytologic diagnosis by bronchoalveolar lavage. Diagnost Cytopathol 11:52-55, 1994. |
9. Sawyer JR, Swanson CM, Koller, MA, North PE, and Ross WR: Centromeric instability of Chromosome 1 Resulting in Multibranched Chromosomes, Telomeric Fusions, and "Jumping Translocations" of 1q in a Human Immunodeficiency Virus-Related NonHodgkin's Lymphoma. Cancer 76: 1238-1244, 1995. |
10. Sawyer JR, Swanson CM, Lukacs JL, Hassed SJ, Curtis MA, North PE, Kozlowski KJ, and Pihoker C: Telomeric Fusion and Chromosome Instability in Multiple Tissues of a Patient with Mosaic Turner's Syndrome. Amer. J. Med. Gen. 69: 383-387, 1997. |
11. Chen B, North PE, and Parham DM: A Novel Polymorphism in Intron 12 of the Dystrophin Gene and its Implications for Deletion Detection by Multiplex PCR. Gene 209: 211-217, 1998. |
12. Sawyer JR, Swanson CM, North PE, Nicholas R, and Thomas JR: Evidence for an association of 6q 13-21 chromosomal aberrations and locally aggressive behavior in cartilage tumors. Cancer 82:474-483, 1998. |
13. Dornhoffer JL, Colvin GB, and North P: Evidence of residual disease in ossicles of patients undergoing cholesteatoma removal. Acta Otolaryngol. 119: 89-92, 1999. |
14. Palmer HE, North P, Nicholas RW, Woodruff J, Allison JW, and Parham DM: Extraskeletal myxoid chondrosarcoma, pathologic case of the month. Arch Pediatr Adoles Med: 11071108, 1999. |
15. North PE and Mihm MC, Jr: The Surgical Pathology Approach to Pediatric Vascular Tumors and Anomalies, in Hemangiomas and Vascular Malformations of the Head and Neck, Waner M and Suen, J, eds, John P. Wiley and Sons, New York, pp 93-170, 1999. |
16. North PE, Mizeracki A, Waner M, and Mihm MC, Jr: GLUT1: A newly discovered marker for juvenile hemangiomas. Human Pathology: 31(1):11-22, 2000. |
17. North PE, Mizeracki A, Mihm MC, Jr., and Mrak RE: GLUT1 immunoreaction patterns reliably distinguish hemangioblastoma from metastatic renal cell carcinoma. Clin Neuropathol. 19 (3): 131-137, 2000. |
18. Uc A, North PE, and Burks W: Esophageal candidiasis in an infant with reflux esophagitis. J Pediatric Gastroenterol Nut. 31(5): 572-4, 2000. |
19. North PE and Nelson R: Molecular Diagnosis of Infectious Disease. Pediatr Commentary 8(2): 16-21, 2000. |
20. North PE, Waner M, Mizeracki A, Mrak RE, Nicholas R, Kincannon J, Suen JY, and Mihm MC, Jr: A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol. 137: 559-570-12, 2001. |
21. Redman JF and North PE: Discrete venous malformation (cirsoid tumor) in boys. J Urology. 165(2): 593-594, 2001. |
22. Redman JF, Ick KA, and North PE: Perineal lipoma and an accessory labial fold in a female neonate. J Urology. 166:1450, 2001. |
23. North PE, Waner M, James CJ, Mizeracki A, Frieden IJ, and Mihm MC, Jr. Congenital nonprogressive hemangioma: a distinct clinicopathological entity unlike infantile hemangioma. Arch Dermatol. 137: 1607-1620, 2001. |
24. North PE and Mihm MC, Jr: Histopathological diagnosis of infantile hemangiomas and vascular malformations, in Vascular Lesions, Hochman M, ed., Facial Plastic Surgery Clinics of North America. 9:505-524, 2001. |
25. Walter JW, North PE, Waner M, Mizeracki A, Blei F, Walker JWT, Reinisch JF, and Marchuk DA. Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma. Genes, Chromosomes , and Cancer . 33:295-303, 2002. |
26. Martinez MI, Sanchez-Carpintero I, North PE, and Mihm MC: Infantile Hemangioma: Clinical resolution with 5% imiquimod cream. Arch Dermatol. 138:881-884, 2002. |
27. Parham DP, Ready R, Stine K, Quiggins C, Becton D, and North P: Comparison of manual and automated leukocyte counts for determination of the absolute neutrophil count: application to a pediatric oncology clinic. Med Pediatr Oncol. 38:183-186, 2002. |
28. North PE, Waner M, and Brodsky MC. Are infantile hemangiomas of placental origin? Ophthalmol. 109: 633-634, 2002. |
29. North PE. New Insights into the Origin of Infantile Hemangioma: A Link to the Placenta, Pediatr Commentary 10: 4-7, 2002. |
30. North PE, Anthony D, Young TL, Brown HH, Waner M, and Brodsky MC: Retinal neovascular markers in retinopathy of prematurity: etiological implications. Br J Ophthalmol. 87(3):275-278, 2003. |
31. Waner M, North PE, Scherer K, Frieden I, Mihm M: The non-random distribution of facial hemangiomas. Arch Dermatol 139:869-875, 2003. |
32. North PE, Hull C, and Kincannon J: Vascular Neoplasms and Neoplastic-Like Proliferations, in Dermatology, Bolognia JL, Jorizzo JL, and Rapini RP, eds., Mosby, London, pp 1817-1841, 2003. |
33. Sanchez-Carpintero I, Mihm MC, Waner M, Mizeracki A, and North PE: Epithelial and mesenchymal hamartomatous changes in mature port-wine stains: morphological evidence for a multiple germ layer field defect. J Am Acad Dermatol 50(4): 606-612, 2004. |
34. Wheeler JG, Tran TC, North P, Beavers-May T, Schutze GE, snow SL: Barriers to public health management of a pertussis outbreak in Arkansas. Arch Pediatr Adol Med 158: 146152, 2004. |
35. Kniestedt C, Brodsky MC, North PE, Waner M, Landau K: Infantile orofacial hemangioma with ipsilateral peripapillary excavation in girls - a variant of the PHACE syndrome Arch Ophthalmol 122: 1-3, 2004. |
36. Shafirstein G, Baumler W, Lapidot M, Ferguson S, North PE, Waner M: A new mathematical approach to the diffusion theory for laser tissue interaction modeling and its implication in laser treatment of port-wine stains. Lasers in Surg Med 34:335-347, 2004. |
37. North PE. Vascular Anomalies: The Multidisciplinary Approach, Pediatr Commentary 12: 21, 2004. |
38. North PE, Kahn T, Cordisco MR, Dadras SS, Detmar M, Frieden IJ: Multifocal lymphangioendotheliomatosis with thrombocytopenia: a newly recognized clinicopathological entity. Arch Dermatol 140(5): 599-606, 2004. |
39. Lyons LL, North PE, Mac-Moune Lai F, Stoler MH, Folpe AL, Weiss SW: Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol 28(5):559-68, 2004. |
40. Dadras SS, North PE, Bertoncini J, Mihm MC, and Detmar M. Infantile Hemangiomas Are Arrested in an Early Developmental Vascular Differentiation State Mod Pathol 17(9):1068-79, 2004. |
41. Frieden IJ, Haggstrom AN, Drolet BA, Mancini AJ, Friedlander SF, Boon L, Chamblin L, Baselga E, Garzon M, Nopper AJ, Siegel DH, Mathes EW, Goddard DS, Biscoff J, North PE, Esterly NB. Infantile Hemangiomas: Current Knowledge, Future Directions. Ped Dermatol 22: 383-406, 2005. |
42. North PE. Molecular Diagnostics in Real-Time, Pediatr Commentary 13, 2005. |
43. Sanchez-Carpintero I, North PE, Mihm MC. Melanoma arising in giant congenital naevi, WHO Classification of Tumors, Pathology and Genetics of Skin Tumors, Lyon, 2006, pp. 83-84. |
44. Thrailkill KM, Moreau CS, Cockrell G, Simpson P, Goel R, North PE, Fowlkes JL, Bunn RC. Physiological matrix metalloproteinase concentrations in serum during childhood and adolescence, using Luminex® Multiplex technology. Clin Chem Lab Med 43(12):1392-9, 2005. |
45. Puri SK, Dornhoffer JL, and North PE. Contact Dermatitis to Silicone Following Cochlear Implantation, the Laryngoscope 115(10):1760-2, 2005. |
46. North PE. Molecular Diagnostics in Real-Time, Pediatr Commentary 13, 2005. |
47. Lawley LP, Cerimele F, Weiss SW, North PE, Cohen C, Kozakewich HPW, Mulliken JB, Arbiser JL. Expression of WT1 distinguishes vascular malformations from proliferative endothelial lesions. Arch Dermatol 141(10):1297-300, 2005. |
48. North PE, Mihm MC: Hemangioma of Infancy. WHO Classification of Tumors, Pathology and Genetics of Skin Tumors, Lyon, 2006, p. 233. |
49. North PE, Waner M, Buckmiller L, James CA, Mihm MC. Vascular tumors of infancy and childhood: beyond capillary hemangioma. Cardiovasc Pathol 15:303-317, 2006. |
50. Nord KM, Kandel J, Lefkowitch JH, Lobritto SJ, Morel KD, North PE, Garzon MC. Multiple Cutaneous Infantile Hemangioma Associated with Hepatic Angiosarcoma. Pediatrics 118(3):907-13, 2006. |
51. Benouni S, Kos L, Ruggeri SY, North PE, Drolet BA. Clear Cell Papulosis in Hispanic Siblings. Arch Dermatol 143(3):358-60, 2007. |
52. Richter G, North PE, Suen JY, James CA, Buckmiller L. Arteriovenous Malformations of the Tongue: A Spectrum of Disease. Laryngoscope 117(2):328-3, 2007. |
53. Goel R, Boylan B, Gruman L, Newman P, North PE, Newman D. The proinflammatory phenotype of PECAM-1-deficient mice results in atherogenic diet-induced steatohepatitis. Am J Physiol: GI Liver Physiol 293(6):G1205-14, 2007. |
54. Zhang R, Ghosh SN, Zhu D, North PE, Fish BL, Morrow NV, Lowry T, Nanchal R, Jacobs ER, Moulder JE, Medhora M. Structural and functional alterations in the rat lung following whole thoracic irradiation with moderate doses: injury and recovery. Int J Radiat Biol 84(6):487-97, 2008. |
55. North PE and Kincannon J: Vascular Neoplasms and Neoplastic-Like Proliferations, in Dermatology, Second Edition, Bolognia JL, Jorizzo JL, and Rapini RP, eds., Mosby, London, 2008. |
56. Deyrup A, Miettinen M, North PE et al. Angiosarcomas arising in the viscera and soft tissue of children and young adults: a clinicopathological study of 15 cases. Am J Surg Pathol 33(2):264-269, 2009. |
57. North PE. Vascular tumors and malformations of infancy and childhood. Pathology Case Reviews 13(6):213-235, 2009. |
58. Badi AN, Kerschner JE, North PE, Drolet BA, Messner A, Perkins JA. Histopathologic and immunophenotypic profile of subglottic hemangioma: a multicenter study. Int J Pediatr Otolaryngology 73(9):1187-91, 2009. |
59. Sieber F, Muir SA, Cohen EP, North PE, Fish BL, Irving AA, Mader M, Moulder JE. High-dose selenium for the mitigation of radiation injury: a pilot study in a rat model. Radiation Research 171(3):368-373, 2009. |
60. Maronn M, Catrine K, North P, Browning MB, Kerschner JE, Noel R, Drolet BA, Kelly M. Expanding the phenotype of multifocal lymphangioendotheliomatosis with thrombocytopenia. Pediatric Blood & Cancer 52(4):531-534, 2009. |
61. Pramanik K, Chun CZ, Garnaas MK, Samant G, Mull A, Li K, North PE and Ramchandran R. Dusp-5 and Snrk-1 coordinately function during vascular development and disease. Blood 113(5):1184-1191, 2009. |
62. Li K, Blum Y, Verma A, Liu Z, Pramanik K, Leigh NR, Chun CZ, Samant GV, Zhao B, Garnaas MK, Horswill MA, Stanhope SA, North PE, Miao RQ, Wilkinson GA, Affolter M, Ramchandran R. A noncoding antisense RNA in tie-1 locus regulates tie-1 function in vivo. Blood 115(1):133-9, 2010. |
63. Si-Tayeb K, Noto FK, Nagaoka M, Li J, Battle MA, Duris C, North PE, Dalton S, Duncan SA. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 51(1):297-305, 2010. |
64. Fu G, Chen Y, Yu M, Podd A, Shuman J, He Y, Lie D, Yassai M, Haribhai D, North PE, Gorski J, Williams CB, Wang D, and Wen R. Phospholipase Cγ1 is essential for T-cell development, activation, and tolerance. J Exp Med 207(2):309-18, 2010. |
65. Le Huu AR, Jokinen CH, Ruben BP, Bruckner A, Weiss SW, North PE, and Dadras SS. Expression of PROX1, lymphatic endothelial transcription factor, in kaposiform hemangioendothelioma and tufted angioma Am J Surg Pathol 34(11):1563-73, 2010. |
66. Benoit MM, North PE, McKenna MJ, Mihm MC, Johnson MM, and Cunningham MJ. Facial nerve hemangiomas: vascular tumors or malformations? Otolaryngol - Head & Neck Surg 142(1): 108-114, 2010. |
67. Campbell CA, Beckum KM, Hammers YA, North PE, Drolet BA. Multiple congenital red-brown macules, thrombocytopenia, and gastrointestinal bleeding. Diagnosis: Multifocal lymphangioendotheliomatosis with thrombocytopenia (MLT). Pediatr Dermatol 27(4):395-6, 2010. |
68. North PE: Pediatric Vascular Tumors and Malformations, Surg Pathol Clin. 2010 Sep;3(3):455-94. doi: 10.1016/j.path.2010.07.002. Review. PMID: 26839221.. |
69. Deyrup AT, Miettinen M, North PE, Khoury JD, Tighiouart M, Spunt SL, Parham D, Shehata BM, and Weiss SW. Pediatric cutaneous angiosarcomas: a clinicopathological study of 10 cases. Am J Surg Pathol 35(1):70-75, 2011. |
70. Williams JM, Zhang J, North P, Lacy S, Yakes M, Dahly-Vernon AJ, Roman R. Evaluation of metalloprotease inhibitors on hypertension and diabetic nephropathy, Am J Physiol Renal Physiol 300(4):F983-98, 2011. |
71. Moreno C, Stodola T, Didier D, Lazar J, Geurts A, North PE, Greene A. Creation and characterization of a renin knock-out rat. Hypertension 57(3):614-9, 2011. |
72. Zhixin Li, Wells CW, North PE, Kumar S, Duris CB, McIntyre JA, Ming Zhao. Phosphatidylethanolamine at the luminal endothelial surface--implications for hemostasis and thrombotic autoimmunity. Clinical & Applied Thrombosis/Hemostasis. 17(2):158-63, 2011. |
73. Noel RJ, Duffy KJ, Kelly ME, Tondravi N, North PE, Drolet BA. Endoscopic management of gastrointestinal bleeding from multifocal lymphangioendotheliomatosis with thrombocytopenia (MLT): limited efficacy and complications. J Pediatr Gastroenterol Nutr. 54(6):822-4, 2011. |
74. Daramola OO, Chun RH, Nash JJ, Drolet BA, North PE, Jensen JN, Kerschner JE. Surgical treatment of infantile hemangioma in a multidisciplinary vascular anomalies clinic. Int J Pediatr Otorhinolaryngol 75(10):1271-4, 2011. |
75. Fisher JB, Kim MS, Blinka S, Ge ZD, Wan T, Duris C, Christian D, Twaroski K, North P, Auchampach J, Lough J. Stress-induced cell-cycle Activation in Tip60 haploinsufficient adult cardiomyocytes. PLoS One 7(2):e31569, 2012. |
76. Zhang Q, Pan J, North PE, Yang S, Lubet RA, Wang Y, You M. Aerosolized 3bromopyruvate inhibits lung Tumorigenesis without causing liver toxicity. Cancer Prev Res (Phila). 5(5):717-25, 2012. |
77. Kothinti RK, Blodgett AB, North PE, Roman RJ, Tabatabai NM. A novel SGLT is expressed in the human kidney. European Journal of Pharmacology 690(1-3):77-83, 2012. |
78. Aboutalebi A, Jessup CJ, North PE, Mihm MC, Jr. Histopathology of Vascular Anomalies. Facial Plast Surg 28:545-553, 2012. |
79. North PE and Kincannon J: Vascular Neoplasms and Neoplastic-Like Proliferations, in Dermatology, Third Edition, Bolognia JL, Jorizzo JL, and Rapini RP, eds., Mosby, London, June 2012. |
80. Kerschner JE, Hong W, Taylor SR, Kerschner JA, Khampang P, Wrege KC, North PE. A novel model of spontaneous otitis media with effusion (OME) in the Oxgr1 knock-out mouse. Int J Pediatr Otorhinolaryngol. 77(1):79-84, 2013. |
81. An J, Waitara MS, Bordas M, Arumugam V, Hoffmann RG, Petrich BG, Sinha U, North P, Sood R. Heparin rescues factor V Leiden-associated placental failure independent of anticoagulation in a murine high-risk pregnancy model. Blood. 2013 Mar 12;121(11):2127-34. PMID: 23325830 |
82. Kilari S, Remadevi I, Zhao B, Pan J, Miao R, Ramchandran R, North PE, You M, Rahimi N, Wilkinson GA. Endothelial cell-specific chemotaxis receptor (ECSCR) enhances vascular endothelial growth factor (VEGF) receptor-2/kinase insert domain receptor (KDR) activation and promotes proteolysis of internalized KDR. J Biol Chem. 2013 April 12;228(15):10265-74. PMID: 23393131 |
83. Fang J, Nurden P, North P, Nurden AT, Du LM, Valentin N, Wilcox DA. C560Rβ3 to bind fibrinogen continuously, but resulted in a severe bleeding syndrome and increased murine mortality. J Thromb Hemost. 2013 Jun; 11(6):1163-71. PMID: 23551977 |
84. Shirley MD, Tang H, Gallione CJ, Baugher JD, Frelin LP, Cohen B, North PE, Marchuk DA, Comi AM, Pevsner J. Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med. 2013 May 23;368(21):1971-9. PMID: 23656586 |
85. Jacob HJ, Abrams K, Bick DP, Brodie K, Dimmock DP, Farrell M, Geurts J, Harris J, Helbling D, Joers BJ, Kliegman R, Kowalski G, Lazar J, Margolis DA, North P, Northup J, Roquemore-Goins A, Scharer G, Shimoyama M, Strong K, Taylor B, Tsaih SW, Tschannen MR, Veith MR, Veith RL, Wendt-Andrae J, Wilk B, Worthey EA. Genomics in clinical practice: Lessons from the front lines. Sci Transl Med. 2013 Jul 17;5(194):194cm5. PMID: 23863829 |
86. Wang B. Zhao B. North P. Kong A. Huang J. Miao QR. Expression of NgBR is highly associated with estrogen receptor alpha and survivin in breast cancer. PLoS ONE [Electronic Resource]. 8(11):e78083, 2013. |
87. Bayer ML. Frommelt PC. Blei F. Breur JM. Cordisco MR. Frieden IJ. Goddard DS. Holland KE. Krol AL. Maheshwari M. Metry DW. Morel KD. North PE. Pope E. Shieh JT. Southern JF. Wargon O. Siegel DH. Drolet BA. Congenital cardiac, aortic arch, and vascular bed anomalies in PHACE syndrome (from the International PHACE Syndrome Registry). American Journal of Cardiology. 112(12):1948-52, 2013 Dec 15. |
88. Tabatabai NM, North PE, Regner KR, Kumar SN, Duris CB, Blodgett AB. De Novo expression of sodium-glucose co-transporter SGLT2 in Bowman's capsule coincides with replacement of parietal epithelial cell layer with proximal tubule-like epithelium. J Membr Biol 2014 Aug; 24(8):675-83. PMID: 24906870 |
89. Flister MJ, Endres BT, Rudemiller N, Sarkis AB, Santarriaga S, Lemke A, Roy I, Geurts AM, Moreno C, Ran S, Tsaih SW, De Pons J, Carlson D, Tan W, Fahrenkrug SC, Lazarova Z, Lazar J, North PE, LaViolette PS, Dwinell MB, Shull JD, Jacob HJ. CXM - A new tool for mapping breast cancer risk in the tumor microenvironment. Cancer Res. 2014 Aug 29. PMID: 25172839 |
90. Lee EE, Ma J, Sacharidou A, Mi W, Salato VK, Nguyen N, Jiang Y, Pascual JM, North PE, Shaul PW, Mettlen M, Wang RC. A Protein Kinase C Phosphorylation Motif in GLUT1 Affects Glucose Transport and is Mutated in GLUT1 Deficiency Syndrome. Mol Cell. 2015 Jun 4;58(5):845-53. PMID: 25982116 |
91. Darrow DH, Greene AK, Mancini AJ, Nopper AJ; Diagnosis and Management of Infantile Hemangioma. Pediatrics. 2015 Oct;136(4):e1060-104. doi: 10.1542/peds.20152485. PMID: 26416931 |
92. North PE: Histology of Vascular Malformations, in Hemangiomas and Vascular Malformations: An Atlas of Diagnosis and Treatment, 2nd Edition, Mattassi R, Loose, DA, Vaghi M, eds, Springer, Milan, 2015. |
93. Darrow DH, Greene AK, Mancini AJ, Nopper AJ; Diagnosis and Management of Infantile Hemangioma: Executive Summary. Pediatrics. 2015 Oct;136(4):786-91. doi: 10.1542/peds.2015-2482. PMID:26416928 |
94. Durand MJ, Zinkevich NS, Riedel M, Gutterman DD, Nasci VL, Salato VK, Hijjawi JB, Reuben CF, North PE, Beyer AM.Vascular Actions of Angiotensin 1-7 in the Human Microcirculation: Novel Role for Telomerase. Arterioscler Thromb Vasc Biol. 2016 Jun;36(6):1254-62. PMID: 27079876 |
95. Rana U, Liu Z, Kumar SN, Zhao B, Hu W, Bordas M, Cossette S, Szabo S, Foeckler J, Weiler H, Chrzanowska-Wodnicka M, Holtz ML, Misra RP, Salato V, North PE, Ramchandran R, Miao QR. Nogo-B receptor deficiency causes cerebral vasculature defects during embryonic development in mice. Dev Biol. 2016 Feb 15;410(2):190-201. PMID: 26746789. |
96. Bick D, Fraser PC, Gutzeit MF, Harris JM, Hambuch TM, Helbling DC, Jacob HJ, Kersten JN, Leuthner SR, May T, North PE, Prisco SZ, Schuler BA, Shimoyama M, Strong KA, Van Why SK, Veith R,Verbsky J, Weborg AM Jr., Wilk BM, Willoughby RE Jr, Worthey EA, Dimmock DP. Successful Application of Whole Genome Sequencing in a Medical Genetics Clinic. J Pediatr Genet 2016;00:1-17. PMID: 28496993 |
97. Gertel AJ, Southwood JE, North PE, Poetker DM, Loehrl TA.Venous malformation of the ethmoid and sphenoid sinuses. Am J Otolaryngol. 2016 Jan-Feb;37(1):12-16. PMID: 2670025211. |
98. Sander T and North PE, Eds: Vascular Tumors and Developmental Malformations: Pathogenic Mechanisms and Molecular Diagnosis, Molecular and Translational Medicine Book Series, Humana Press (Springer), New York, NY, 2016. |
99. Szabo S and North PE, Histopathology and Pathogenesis of Vascular Anomalies, in Vascular Tumors and Developmental Malformations: Pathogenic Mechanisms and Molecular Diagnosis, Molecular and Translational Medicine Book Series, Humana Press (Springer), New York, NY, 2016. |
100. Comi AM, Sahin M, Hammill A, Kaplan EH, Juhász C, North P, Ball KL, Levin AV, Cohen B, Morris J, Lo W, Roach ES. Leveraging a Sturge-Weber gene discovery: an agenda for future research. 2015 Sturge-Weber Syndrome Research Workshop. Pediatr Neurol. 2016 May;58:12-24. doi: 10.1016/j.pediatrneurol.2015.11.009. PMID: 27268758. |
101. Tomasiewicz HG, Johnson BA, Liu XC, North P et al. Development of Zebrafish (Danio rerio) as a natural model system for studying scoliosis . J Orthop Surg Rehabil 2017;1(1):1-2. |
102. Brockman RM, Humphrey SR, Moe DC, North PE, King DM, Jensen JN, Siegel DH, Drolet BA. Mimickers of Infantile Hemangiomas. Pediatr Dermatol. 2017 May;34(3):331-336. doi: 10.1111/pde.13127. PMID: 28523875 |
103. Bergmann AJ, North PE, Vasquez L, Bello H, Gastañaga Ruiz M, Anderson KA. Multiclass chemical exposure in rural Peru using silicone wristbands. J Expos Sci Environ Epidemiol 2017 Nov;27(6):560-568 PMID: 28745304 PMCID: PMC5658680. |
104. Cajaiba MM, North PE, Gong S, Dickman PS, Mroczek-Musulman E, Sauer DA, and Perlman EJ. Congenital Capillary Proliferation of the Kidney: a Distinctive Renal Vascular Lesion of Childhood. Hum Pathol, 2017 Aug;66:59-66 PMID: 28554576. |
105. Lapinski PE, Doosti A, Salato V, North P, Burrows PE, King PD. Somatic second hit mutation of RASA1 in vascular endothelial cells in capillary malformation-arteriovenous malformation. Eur J Med Genet 2017 Oct 09 PMID: 29024832. |
106. Huang H, Gheorghe G, North PE, Suchi M. Expanding the Phenotype of ALK-positive Histiocytosis: A Report of 2 Cases. Pediatr Dev Pathol. 2018 Sep-Oct;21(5):449-455. doi: 10.1177/1093526617740784. Epub 2017 Dec 9. PMID: 29224419. |
107. Kim J, Fons RA, Scott JP, Eriksen CM, Lerret SM, Browning MB, Telega GW, Vitola BE, Hoffman GM, North PE, Vo NN, Zimmerman MA, Hong JC. Transabdominal Intrapericardial Approach in Liver Transplantation for Unresectable Primary Hepatic Functioning Paraganglioma with Invasion into Hepatic veins and Suprahepatic Vena Cava: A Surgical and Anesthesia Management Challenge. Transplant Proc. 2018 Nov;50(9):2630-2635. doi: 10.1016/j.transproceed.2018.02.189. Epub 2018 Mar 20. PMID: 30401364. |
108. Miller JJ, Aoki K, Mascari CA, Beltrame AK, Sokumbi O, North PE, Tiemeyer M, Kriegel AJ, Dahms NM. α-Galactosidase A-deficient rats accumulate glycosphingolipids and develop cardiorenal phenotypes of Fabry disease. FASEB J. 2018 Jul 6:fj201800771R. doi: 10.1096/fj.201800771R. [Epub ahead of print] PMID: 29979634. |
109. North PE: Classification and pathology of congenital and perinatal vascular anomalies of the head and neck, in Congenital Vascular Lesions of the Head and Neck; Teresa M O and Milton Waner, eds, Otolaryngol Clin North Am. 2018 Feb;51(1):1-39. doi: 1016/j.otc.2017.09.020. Review. PMID:29217054 |
110. Spires D, Ilatovskaya DV, Levchenko V, North PE, Geurts AM, Palygin O, Staruschenko A. Protective role of Trpc6 knockout in the progression of diabetic kidney disease. Am J Physiol Renal Physiol. 2018 Oct 1;315(4):F1091-F1097. doi: 10.1152/ajprenal.00155.2018. Epub 2018 Jun 20. PMID: 29923767. |
111. De la Torre AJ, Luat AF, Ho JC, Lan M, Argersinger DP, Cavuoto KM, Enriquez Algeciras M, Tikkanen S, North PE, Burkhart CN, Chugani HT, Ball KL, Pinto AL, Loeb JA. A Multidisciplinary Consensus for Clinical Care and Research Needs for Sturge- Weber Syndrome, Pediatr Neurol 2018 Jul;84:11-20 PMID: 29803545 |
112. North PE: Vascular Neoplasms and Neoplastic-Like Proliferations, in Dermatology, Fourth Edition, Bolognia JL, Schaffer, and Cerroni eds., Elsevier, London, 2018. |
113. North PE: Hemangioma of Infancy. WHO Classification of Skin Tumors, Lyon, 2018. |
114. Dixon HM, Armstrong G, Barton M, Bergmann AJ, Bondy M, Halbleib ML, Hamilton W, Haynes E, Herbstman J, Hoffman P, Jepson P, Kile ML, Kincl L, Laurienti PJ, North P, Paulik LB, Petrosino J, Points GL 3rd, Poutasse CM, Rohlman D, Scott RP, Smith B, Tidwell LG, Walker C, Waters KM, Anderson KA. Discovery of common chemical exposures across three continents using silicone wristbands. R Soc Open Sci. 2019 Feb 6;6(2):181836. doi: 10.1098/rsos.181836. eCollection 2019 Feb. PMID: 30891293 |
115. Schlaak RA, Frei A, Schottstaedt AM, Tsaih SW, Fish BL, Harmann L, Liu Q, Gasperetti T, Medhora MM, North PE, Strande JL, Sun Y, Rui H, Flister MJ, Bergom C. Mapping Genetic Modifiers of Radiation-Induced Cardiotoxicity to Rat Chromosome 3. Am J Physiol Heart Circ Physiol. 2019 Mar 8. doi: 10.1152/ajpheart.00482.2018. [Epub ahead of print] PMID: 30848680. |
116. Dixon HM, Armstrong G, Barton M, Bergmann AJ, Bondy M, Halbleib ML, Hamilton W, Haynes E, Herbstman J, Hoffman P, Jepson P, Kile ML, Kincl L, Laurienti PJ, North P, Paulik LB, Petrosino J, Points GL 3rd, Poutasse CM, Rohlman D, Scott RP, Smith B, Tidwell LG, Walker C, Waters KM, Anderson KA. Discovery of common chemical exposures across three continents using silicone wristbands. R Soc Open Sci. 2019 Feb;6(2):181836. PMCID: PMC6408398 |
117. Schlaak RA, Frei A, Schottstaedt AM, Tsaih SW, Fish BL, Harmann L, Liu Q, Gasperetti T, Medhora M, North PE, Strande JL, Sun Y, Rui H, Flister MJ, Bergom C. Mapping genetic modifiers of radiation-induced cardiotoxicity to rat chromosome 3. Am J Physiol Heart Circ Physiol. 2019 Jun 01;316(6):H1267-H1280. PMCID: PMC6620678 |
118. Blumenthal S, Stefanko N, Cossio ML, Coulombe J, McCuaig C, Dubois J, North P, Drolet B. Multifocal congenital hemangioma: Expanding the pathogenesis of "neonatal hemangiomatosis". Pediatr Dermatol. 2019 Sep;36(5):720-722. |
119. Chen D, Teng JM, North PE, Lapinski PE, King PD. RASA1-dependent cellular export of collagen IV controls blood and lymphatic vascular development. J Clin Invest. 2019 Jun 11;129(9):3545-3561. PMCID: PMC6715364 |
120. Lenarczyk M, Kronenberg A, Mäder M, North PE, Komorowski R, Cheng Q, Little MP, Chiang IH, LaTessa C, Jardine J, Baker JE. Age at Exposure to Radiation Determines Severity of Renal and Cardiac Disease in Rats. Radiat Res. 2019 Jul;192(1):63-74. PMCID: PMC10654917 |
121. Lenarczyk M, Kronenberg A, Mäder M, North PE, Komorowski R, Cheng Q, Little MP, Chiang IH, LaTessa C, Jardine J, Baker JE. Age at Exposure to Radiation Determines Severity of Renal and Cardiac Disease in Rats. Radiat Res. 2019 Jul;192(1):63-74. PMCID: PMC10654917 |
122. Brandt ZJ, North PN, Link BA. Somatic Mutations of <i>lats2</i> Cause Peripheral Nerve Sheath Tumors in Zebrafish. Cells. 2019 Aug 25;8(9). PMCID: PMC6770745 |
123. Jakubowski LA, Chun RH, Drolet BA, Jensen JN, North PE. Misdiagnosed as infantile hemangioma: Early presentation of small vessel-rich AVM International Journal of Pediatric Otorhinolaryngology Extra. September 2013;8(3):71-74. |
124. North PE. Vascular tumors and malformations of infancy and childhood Pathology Case Reviews. November 2008;13(6):213-235. |
125. Shafirstein G, Bäumler W, Lapidoth M, Ferguson S, North PE, Waner M. Laser tissue interaction modeling for treatment planning of port-wine stain Conference Proceedings - Lasers and Electro-Optics Society Annual Meeting-LEOS. 2003;1:313-315. |
126. Sasaki M, North PE, Elsey J, Bubley J, Rao S, Jung Y, Wu S, Zou MH, Pollack BP, Kumar J, Singh H, Arbiser JL. Propranolol exhibits activity against hemangiomas independent of beta blockade. NPJ Precis Oncol. 2019;3:27. PMCID: PMC6825155 |
127. Martinez AP, Zapata M, North PE, Folpe AL, Weiss SW. Lymphatic-type "Angiosarcoma" With Prominent Lymphocytic Infiltrate. Am J Surg Pathol. 2020 Feb;44(2):271-279. |
128. Zangwill SD, Kindel SJ, Ragalie WS, North PE, Pollow A, Hidestrand M, Tomita-Mitchell A, Stamm KD, Mitchell ME. Early changes in cell-free DNA levels in newly transplanted heart transplant patients. Pediatr Transplant. 2020 Feb;24(1):e13622. PMCID: PMC7065377 |
129. North PE, Ziegler E, Mahnke DK, Stamm KD, Thomm A, Daft P, Goetsch M, Liang HL, Baker MA, Vepraskas A, Rosenau C, Dasgupta M, Simpson P, Mitchell ME, Tomita-Mitchell A. Cell-free DNA donor fraction analysis in pediatric and adult heart transplant patients by multiplexed allele-specific quantitative PCR: Validation of a rapid and highly sensitive clinical test for stratification of rejection probability. PLoS One. 2020;15(1):e0227385. PMCID: PMC6957190 |
130. Richmond ME, Zangwill SD, Kindel SJ, Deshpande SR, Schroder JN, Bichell DP, Knecht KR, Mahle WT, Wigger MA, Gaglianello NA, Pahl E, Simpson PM, Dasgupta M, North PE, Hidestrand M, Tomita-Mitchell A, Mitchell ME. Donor fraction cell-free DNA and rejection in adult and pediatric heart transplantation. J Heart Lung Transplant. 2020 May;39(5):454-463. |
131. Brandt ZJ, Echert AE, Bostrom JR, North PN, Link BA. Core Hippo pathway components act as a brake on Yap and Taz in the development and maintenance of the biliary network. Development. 2020 Jun 22;147(12). PMCID: PMC7328147 |
132. Scott JP, Ragalie WS, Stamm KD, Mahnke DK, Liang HL, Simpson PM, Dasgupta M, Katz R, North PE, Tomita-Mitchell A, Zangwill SD, Kindel SJ, Mitchell ME. Total Cell-Free DNA Predicts Death and Infection Following Pediatric and Adult Heart Transplantation. Ann Thorac Surg. 2021 Oct;112(4):1282-1289. |
133. Hu W, Liu Z, Salato V, North PE, Bischoff J, Kumar SN, Fang Z, Rajan S, Hussain MM, Miao QR. NOGOB receptor-mediated RAS signaling pathway is a target for suppressing proliferating hemangioma. JCI Insight. 2021 Feb 08;6(3). PMCID: PMC7934876 |
134. Lenarczyk M, Laiakis EC, Mattson DL, Johnson BD, Kronenberg A, North PE, Komorowski R, Mäder M, Baker JE. Irradiation of the kidneys causes pathologic remodeling in the nontargeted heart: A role for the immune system. FASEB Bioadv. 2020 Dec;2(12):705-719. PMCID: PMC7734425 |
135. Puzyrenko A, Jacobs ER, Sun Y, Felix JC, Sheinin Y, Ge L, Lai S, Dai Q, Gantner BN, Nanchal R, North PE, Simpson PM, Rui H, Benjamin IJ. Pneumocytes are distinguished by highly elevated expression of the ER stress biomarker GRP78, a co-receptor for SARS-CoV-2, in COVID-19 autopsies. Cell Stress Chaperones. 2021 Sep;26(5):859-868. PMCID: PMC8357488 |
136. Fu Q, North PE, Ke X, Huang YW, Fritz KA, Majnik AV, Lane RH. Adverse Maternal Environment and Postweaning Western Diet Alter Hepatic CD36 Expression and Methylation Concurrently with Nonalcoholic Fatty Liver Disease in Mouse Offspring. J Nutr. 2021 Oct 01;151(10):3102-3112. PMCID: PMC8485909 |
137. Zangwill SD, Deshpande SR, Simpson PM, Liang HL, Zhang L, Dasgupta M, Richmond ME, Kindel SJ, Bichell DP, Mahle WT, Wigger MA, Schroder JN, Knecht KR, Pahl E, Gaglianello NA, North PE, Tomita-Mitchell A, Mitchell ME. Increase in nuclear cell-free DNA is associated with major adverse events in adult and pediatric heart transplant recipients. Clin Transplant. 2022 Jan;36(1):e14509. |
138. Scott JP, Tanem JM, Tomita-Mitchell A, Hoffman GM, Niebler RA, Liang HL, Simpson PM, Stamm KD, North PE, Mitchell ME. Elevated nuclear and mitochondrial cell-free deoxyribonucleic acid measurements are associated with death after infant cardiac surgery. J Thorac Cardiovasc Surg. 2022 Aug;164(2):367-375. |
139. Sasaki M, Jung Y, North P, Elsey J, Choate K, Toussaint MA, Huang C, Radi R, Perricone AJ, Corces VG, Arbiser JL. Introduction of Mutant GNAQ into Endothelial Cells Induces a Vascular Malformation Phenotype with Therapeutic Response to Imatinib. Cancers (Basel). 2022 Jan 14;14(2). PMCID: PMC8773683 |
140. Galeffi F, Snellings DA, Wetzel-Strong SE, Kastelic N, Bullock J, Gallione CJ, North PE, Marchuk DA. A novel somatic mutation in GNAQ in a capillary malformation provides insight into molecular pathogenesis. Angiogenesis. 2022 Nov;25(4):493-502. PMCID: PMC9529792 |
141. Deshpande SR, Zangwill SD, Kindel SJ, Schroder JN, Bichell DP, Wigger MA, Richmond ME, Knecht KR, Pahl E, Gaglianello NA, Mahle WT, Stamm KD, Simpson PM, Dasgupta M, Zhang L, North PE, Tomita-Mitchell A, Mitchell ME. Relationship between donor fraction cell-free DNA and clinical rejection in heart transplantation. Pediatr Transplant. 2022 Jun;26(4):e14264. |
142. Richmond ME, Deshpande SR, Zangwill SD, Bichell DP, Kindel SJ, Mahle WT, Schroder JN, Wigger MA, Knecht KR, Pahl E, Gaglianello NA, Goetsch MA, Simpson P, Dasgupta M, Zhang L, North PE, Tomita-Mitchell A, Mitchell ME. Validation of donor fraction cell-free DNA with biopsy-proven cardiac allograft rejection in children and adults Journal of Thoracic and Cardiovascular Surgery. 2022. |
143. Tanem JM, Scott JP, Hoffman GM, Niebler RA, Tomita-Mitchell A, Stamm KD, Liang HL, North PE, Bertrandt RA, Woods RK, Hraska V, Mitchell ME. Nuclear Cell-Free DNA Predicts Adverse Events After Pediatric Cardiothoracic Surgery. Ann Thorac Surg. 2023 Aug;116(2):349-356. |
144. Richmond ME, Deshpande SR, Zangwill SD, Bichell DP, Kindel SJ, Mahle WT, Schroder JN, Wigger MA, Knecht KR, Pahl E, Gaglianello NA, Goetsch MA, Simpson P, Dasgupta M, Zhang L, North PE, Tomita-Mitchell A, Mitchell ME. Validation of donor fraction cell-free DNA with biopsy-proven cardiac allograft rejection in children and adults. J Thorac Cardiovasc Surg. 2023 Feb;165(2):460-468.e2. PMCID: PMC9617812 |
145. Puzyrenko A, Jacobs ER, Padilla N, Devine A, Aljadah M, Gantner BN, Pan AY, Lai S, Dai Q, Rubenstein JC, North PE, Simpson PM, Willoughby RE, O'Meara CC, Flinn MA, Lough JW, Ibrahim EH, Zheng Z, Sun Y, Felix J, Hunt BC, Ross G, Rui H, Benjamin IJ. Collagen-Specific HSP47<sup>+</sup> Myofibroblasts and CD163<sup>+</sup> Macrophages Identify Profibrotic Phenotypes in Deceased Hearts With SARS-CoV-2 Infections. J Am Heart Assoc. 2023 Feb 21;12(4):e027990. PMCID: PMC10111490 |
146. Galbraith K, Vasudevaraja V, Serrano J, Shen G, Tran I, Abdallat N, Wen M, Patel S, Movahed-Ezazi M, Faustin A, Spino-Keeton M, Roberts LG, Maloku E, Drexler SA, Liechty BL, Pisapia D, Krasnozhen-Ratush O, Rosenblum M, Shroff S, Boué DR, Davidson C, Mao Q, Suchi M, North P, Hopp A, Segura A, Jarzembowski JA, Parsons L, Johnson MD, Mobley B, Samore W, McGuone D, Gopal PP, Canoll PD, Horbinski C, Fullmer JM, Farooqui MS, Gokden M, Wadhwani NR, Richardson TE, Umphlett M, Tsankova NM, DeWitt JC, Sen C, Placantonakis DG, Pacione D, Wisoff JH, Teresa Hidalgo E, Harter D, William CM, Cordova C, Kurz SC, Barbaro M, Orringer DA, Karajannis MA, Sulman EP, Gardner SL, Zagzag D, Tsirigos A, Allen JC, Golfinos JG, Snuderl M. Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing. Neurooncol Adv. 2023;5(1):vdad076. PMCID: PMC10355794 |
147. Hammond A, North P, Stiff H. Unusual Deep Infantile Hemangioma Presentation with Orbital Involvement. Ophthalmology. 2024 May;131(5):567. |
148. Jacobs ER, Ross GR, Padilla N, Pan AY, Liegl M, Puzyrenko A, Lai S, Dai Q, Uche N, Rubenstein JC, North PE, Ibrahim EH, Sun Y, Felix JC, Rui H, Benjamin IJ. Profibrotic COVID-19 subphenotype exhibits enhanced localized ER-dependent HSP47<sup>+</sup> expression in cardiac myofibroblasts in situ. J Mol Cell Cardiol. 2023 Dec;185:1-12. PMCID: PMC11000691 |
149. North PE. Histology of vascular malformations Hemangiomas and Vascular Malformations: An Atlas of Diagnosis and Treatment. 14 April 2015:171-180. |
150. Deshpande SR, Zangwill SD, Richmond ME, Kindel SJ, Schroder JN, Gaglianello N, Bichell DP, Wigger MA, Knecht KR, Thrush PT, Mahle WT, North PE, Simpson PM, Zhang L, Dasgupta M, Tomita-Mitchell A, Mitchell ME. Evaluating threshold for donor fraction cell-free DNA using clinically available assay for rejection in pediatric and adult heart transplantation. Pediatr Transplant. 2024 May;28(3):e14708. PMCID: PMC10987078 |
151. Ibrahim EH, Rubenstein J, Sosa A, Stojanovska J, Pan A, North P, Rui H, Benjamin I. Myocardial Strain for the Differentiation of Myocardial Involvement in the Post-Acute Sequelae of COVID-19-A Multiparametric Cardiac MRI Study. Tomography. 2024 Feb 27;10(3):331-348. PMCID: PMC10974260 |
Books, Chapters, and Reviews |
1. North PE and Mihm MC, Jr: The Surgical Pathology Approach to Pediatric Vascular Tumors and Anomalies, in Hemangiomas and Vascular Malformations of the Head and Neck, Waner M and Suen, J, eds, John P. Wiley and Sons, New York, pp 93-170, 1999. |
2. North PE and Nelson R: Molecular Diagnosis of Infectious Disease. Pediatr Commentary 8(2): 16-21, 2000. |
3. North PE. New Insights into the Origin of Infantile Hemangioma: A Link to the Placenta, Pediatr Commentary 10: 4-7, 2002. |
4. North PE, Hull C, and Kincannon J: Vascular Neoplasms and Neoplastic-Like Proliferations, in Dermatology, Bolognia JL, Jorizzo JL, and Rapini RP, eds., Mosby, London, pp 1817-1841, 2003. |
5. North PE. Vascular Anomalies: The Multidisciplinary Approach, Pediatr Commentary 12: 21, 2004. |
6. North PE. Molecular Diagnostics in Real-Time, Pediatr Commentary 13, 2005. |
7. North PE and Kincannon J: Vascular Neoplasms and Neoplastic-Like Proliferations, in Dermatology, Second Edition, Bolognia JL, Jorizzo JL, and Rapini RP, eds., Mosby, London, 2008. |
8. North PE: Pediatric Vascular Tumors and Malformations, Surg Pathol Clin. 2010 Sep;3(3):455-94. doi: 10.1016/j.path.2010.07.002. Review. PMID: 26839221.. |
9. North PE and Kincannon J: Vascular Neoplasms and Neoplastic-Like Proliferations, in Dermatology, Third Edition, Bolognia JL, Jorizzo JL, and Rapini RP, eds., Mosby, London, June 2012. |
10. North PE: Histology of Vascular Malformations, in Hemangiomas and Vascular Malformations: An Atlas of Diagnosis and Treatment, 2nd Edition, Mattassi R, Loose, DA, Vaghi M, eds, Springer, Milan, 2015. |
11. Sander T and North PE, Eds: Vascular Tumors and Developmental Malformations: Pathogenic Mechanisms and Molecular Diagnosis, Molecular and Translational Medicine Book Series, Humana Press (Springer), New York, NY, 2016. |
12. Szabo S and North PE, Histopathology and Pathogenesis of Vascular Anomalies, in Vascular Tumors and Developmental Malformations: Pathogenic Mechanisms and Molecular Diagnosis, Molecular and Translational Medicine Book Series, Humana Press (Springer), New York, NY, 2016. |
13. North PE: Vascular Neoplasms and Neoplastic-Like Proliferations, in Dermatology, Fourth Edition, Bolognia JL, Schaffer, and Cerroni eds., Elsevier, London (in press). |
14. North PE: Classification and pathology of congenital and perinatal vascular anomalies of the head and neck, in Congenital Vascular Lesions of the Head and Neck; Teresa M O and Milton Waner, eds, Otolaryngology Clinics, Elsevier, Philadelphia, PA, 2017. |
15. North PE: Hemangioma of Infancy. WHO Classification of Tumors, Pathology and Genetics of Skin Tumors, Lyon, 2018 (in press). |
Abstracts |
1. North P, Fleischer S: The effect of increased membrane cholesterol content on rat brain synaptosomes. Soc Neurosci Abstr 5:1014, 1979. |
2. North P, Fleischer S: Reversible loss of high-affinity, sodium-dependent gamma-aminobutyric acid uptake of synaptic plasma membranes depleted of cholesterol. Soc Neurosci Abstr 7:306, 1981. |
3. North PE, Post RL: Two patterns of inhibition of (Na,K) ATPase by vanadyl ion. Fed Proc 42:1926, 1983. |
4. North PE, Mrak RE: Synaptic membrane transport of choline and of gamma aminobutyric acid (GABA): Effects of ethanol and other n-alcohols. Neurotoxicology 9:689, 1988. |
5. Sawyer JR, Swanson CM, Lukcas JL, Nicholas R, North PE, and Thomas JR: Complex translocations involving 6q13 and chromosomal instability in histologically benign, but locally aggressive cartilaginous lesions. Amer. Soc. Human Genetics Abstr, 1996. |
6. Dornhoffer JL, Colvin GB, North P: Microscopical examination of ossicles in patients with cholesteatoma. Proceedings of the Fifth International Conference on Cholesteatoma and Mastoid Surgery, Sardinia, Italy, 1996. |
7. Sawyer JR, Swanson CM, Lukacs JL, Nicholas RW, North PE, and Thomas, JR: Recurring chromosome breakpoints at 6q13-21 in histologically benign, but locally aggressive cartilaginous lesions. Seventh International Workshop on Chromosomes and Solid Tumors, 1997. |
8. Colby S, Chapman YL, Luo Y, Mitsuhashi M, Moorthy TV, Zoha S, Allnut T, Mizeracki A, North P, Musk P, Eisenberg A, and Smead D: Use of the FMBIO II Imaging System in Diagnostic Assays. Assoc. For Molec. Pathol. Abstr., 1998. |
9. Colby S, Chapman W, Luo Y, Mitsuhashi M, Moorthy TV, Allnut T, North P, Musk P, and Smead D: Using fluorescence detection in molecular diagnostic applications. DNA Technologies in Human Disease Detection Conf. Abstr, 1998. |
10. North PE, Waner MW, Mizeracki A, and Mihm MC, Jr: GLUT1 is a specific marker for juvenile hemangiomas. Lab Invest 79:61A, 1999. |
11. Parham DM,Quiggins C, Ready R, and North PE, Comparison of manual vs. automated leukocyte counts for determination of the absolute neutrophil count. Joint Annual Meeting of the International Society of Paediatric Oncology and the American Society of Pediatric Hematology/Oncology, Montreal, Canada, 1999. |
12. North PE, Waner MW, Mizeracki A, and Mihm MC, Jr.: Unique coexpression of GLUT1, merosin, and Lewis Y antigen by juvenile hemangiomas at all stages. Lab Invest 80:66A, 2000. |
13. North PE, Mizeracki A, Thomas JR, Nicholas R, Waner MW, and Mihm MC, Jr.: Intramuscular "hemangiomas" are vascular malformations immunodistinct from juvenile hemangiomas. Lab Invest 80:14A, 2000. |
14. North PE, Mizeracki A, Waner M, Mihm MC, Jr., and Mrak RE: Do juvenile hemangiomas originate from endoneurial microvasculature? J Neuropath Exp Neurol 59:429, 2000. |
15. North PE and Mihm, MC, Jr.: Juvenile hemangiomas share a unique immunophenotype with the microvasculature of placenta: implications for pathogenesis.13th International Workshop on Vascular Anomalies Abstracts, Montreal, Canada, 2000. |
16. North PE and Mihm MC, Jr.: Pathology of juvenile hemangiomas and vascular malformations. American Academy of Dermatology Abstracts, San Francisco, CA, 2000. |
17. North PE: Frontiers of research in vascular birthmarks. American Academy of Dermatology Abstracts, San Franscisco, CA, 2000. |
18. Brown H, Mizeracki A, Mrak RE, and North PE: Glucose transporter isoform 1 in neovascularized ocular tissue. Assoc. for Research in Vision and Ophthalmology Abstracts, Fort Lauderdale, FL, 2000. |
19. Waner M, Waner A, North P, Mihm MC, Jr., Sigfried I, and Suen JY: Identification of two distinct types of hemangiomas. 13th International Workshop on Vascular Anomalies Abstacts, Montreal, Canada, 2000. |
20. Waner M, Adams D, North P, and Yee S: A rare complication of pulsed dye laser treatment of hemangiomas. 13th International Workshop on Vascular Anomalies Abstracts, Montreal, Canada, 2000. |
21. Walter JW, North PE, Mizeracki A, Waner M, and Marchuk DA: Non-random X-inactivation suggests that juvenile hemangiomas are monoclonally derived. Amer J Human Genet. 67:75 (supp. 2, A341), 2000. |
22. North PE, Mizeracki A, Mihm MC, Jr., and Mrak RE.: GLUT1 immunoreaction patterns reliably distinguish hemangioblastoma from metastatic renal cell carcinoma. Lab Invest 80:195A, 2000. |
23. North PE, Waner MW, Mizeracki A, Mihm MC, Jr.: Diffuse (dermatomal) and focal juvenile hemangiomas are histologically and immunophenotypically similar Mod Pathol; 14(1): 71A, 2001. |
24. North PE, Waner MW, Mizeracki A, Nicholas R, Kincannon J, Gibson D, and Mihm MC, Jr: Placental antigens expressed by juvenile hemangiomas are not present in other benign vascular proliferations Mod Pathol; 14(1):71A, 2001. |
25. Nicholas RW, Thomas JR, Mizeracki A, Waner M, James CJ, Mihm MC, Jr, and North PE. Are intramuscular vascular malformations truly "hemangiomas?" Musculoskeletal Tumor Society Annual Meeting, May 2001. |
26. Walter J, North PE, Mizeracki A, Waner M, and Marchuk D. Somatic mutations in sporadic hemangiomas. Amer J Human Genet., 68, 2001. |
27. Mathew S, Parham DM, Ready R, Quiggins C, Jacobs RF, Maes L, North PE. High interlaboratory variability in pediatric band counts. Mod Pathol 2002; 15(1):254A. February, 2002. |
28. Tyler LN, Parham DP, Glasier CM, Mrak RE, Mizeracki A, Burson GT, and North PE. Immunostaining of focal cortical dysplasia with MIB1 and anti-p53. Mod Pathol; 15(1):6P, 2002. |
29. North PE, Waner M, James CA, Mizeracki A, and Mihm MC, Jr. Congenital nonprogressive hemangioma: a distinct clinicopathological entity unlike infantile hemangioma. Mod Pathol; 15(1):104A, 2002. |
30. North PE, Frieden IJ, McCalmont T, Mizeracki A, Detmar M, and Mihm MC. The morphological spectrum of tufted angioma and kaposiform hemangioendothelioma: a lymphothelial association with coagulopathy. 14th International Workshop on Vascular Anomalies Abstracts, Nijmegen, the Netherlands, June 27, 2002. |
31. DeAos I, Mizeracki A, Waner M, and North PE. Infantile hemangiomas are immunonegative for estrogen (alpha and beta) and progesterone receptors: reassessment of previous assumptions. 14th International Workshop on Vascular Anomalies Abstracts, Nijmegen, the Netherlands, June 27, 2002. |
32. Mizeracki A, Waner M, Davis PF, and North PE. Histological and immunohistochemical analysis of hemangiogenesis in fibrin gels: pericytes first, endothelial cells second. 14th International Workshop on Vascular Anomalies Abstracts, Nijmegen, the Netherlands, June 27, 2002. |
33. Frieden IJ, Kahn K, Cordisco M, and North PE. Multifocal angioendotheliomatosis with coagulopathy. 14th International Workshop on Vascular Anomalies Abstracts, Nijmegen, the Netherlands, June 26, 2002. |
34. James CA, North PE, Nicholas R, and Waner M. Mass lesions in soft tissue arteriovenous malformations: radiologic/pathologic correlation. 14th International Workshop on Vascular Anomalies Abstracts, Nijmegen, the Netherlands, June 27, 2002. |
35. North PE, Frieden IJ, Kincannon J, and Mihm MC. Multiple congenital pyogenic granuloma-like proliferations mimicking diffuse hemangiomatosis: a prototypic case study. 14th International Workshop on Vascular Anomalies Abstracts, Nijmegen, the Netherlands, June 26, 2002. |
36. Sanchez-Carpintero I, North PE, Waner M, Mihm MC. The heterogeneity of cutaneous vascular stains: a clinicopathological study. 14th International Workshop on Vascular Anomalies Abstracts, Nijmegen, the Netherlands, June 27, 2002. |
37. Frieden IJ, Waner M, McCalmont T, and North PE. The histologic spectrum of hemangioma of infancy, 14th International Workshop on Vascular Anomalies Abstracts, Nijmegen, the Netherlands, June 26, 2002. |
38. Shafirstein G, Mizeracki A, North PE, and Waner M. Vascular structure in corrosion casts of arteriovenous malformations (AVMSs), venous malformations (VMs), and hemangiomas. 14th International Workshop on Vascular Anomalies Abstracts, Nijmegen, the Netherlands, June 27, 2002. |
39. North PE, Sanchez-Carpintero I, Waner M, Mizeracki A and Mihm MC. Despite striking clinical dissimilarities segmental and focal infantile hemangiomas are histologically and immunohistochemically identical, 20th World Congress of Dermatology, Paris, France, July 2002. Ann Dermatol Venereol 129:1S686, 2002. |
40. Sanchez-Carpintero I, Martinez MI, North PE, Waner M, and Mihm MC. Imiquimod: remarkable therapy for vascular lesions, 20th World Congress of Dermatology, Paris France, July 2002. Ann Dermatol Venereol 129:1S704, 2002. |
41. North PE, Mizeracki A, Waner M, and Davis P. Ex vivo hemangiogenesis in fibrin gels: a morphological and immunohistochemical analysis. Lab Invest 83(1):18A, 2003. |
42. Lyons LL, North PE, Stoler MH, Folpe AL, Weiss SW. Kaposiform hemangioendothelioma (KH) is histologically, immunohistochemically, and biologically distinct from common (juvenile) hemangioma. Lab Invest 83(1):16A, 2003. |
43. North PE, Sanchez-Carpintero I, Mizeracki A, Waner M, and Mihm MC. The distinctive histology of lip enlargement in port-wine stains: a clinicopathological study. Lab Invest 83(1):96A, 2003. |
44. DeAos I, Mizeracki A, Mihm MC, and North PE. Infantile hemangiomas are immunonegative for estrogen (alpha and beta) and progesterone (A/B) receptors: reassessment of previous assumptions. Lab Invest 83(1):90A, 2003. |
45. DeAos I, Frieden IJ, Kahn T, Cordisco M, Detmar M, and North PE. Multifocal papillary angiomatosis with thrombocytopenia: a new clinicopathological entity. Mod Pathol 16:2p, 2003. |
46. North PE, DeAos I, Lal A, Riggins G, Marchuk DA, Waner M, and Mihm MC. Immune Tolerance in Infantile Hemangioma. International Society for the Study of Vascular Anomalies15th Congress, Wellington, New Zealand, February 23, 2004. |
47. North PE, DeAos I, Hemphill CH, Waner M, Mihm MC. A Mechanism of Skin Homing in Infantile Hemangioma. International Society for the Study of Vascular Anomalies 15th Congress, Wellington, New Zealand, February 23, 2004. |
48. DeAos I, James CA, and North PE. Hepatic "hemangioma": not a singular entity. International Society for the Study of Vascular Anomalies15th Congress, Wellington, New Zealand, February 23, 2004. |
49. North PE, DeAos I, Hemphill CH, Waner M, Mihm MC. D2-40 antibody: limited utility in the diagnosis of kaposiform hemangioendothelioma. International Society for the Study of Vascular Anomalies15th Congress, Wellington, New Zealand, February 22-25, 2004. |
50. North PE, DeAos I, Hemphill CH, Waner M, MC Mihm. Marked differences in the lymphatic compliments of cutaneous infantile and congenital hemangioma. International Society for the Study of Vascular Anomalies 15th Congress, Wellington, New Zealand, February 23, 2004. |
51. Prendiville JS, Brown K, Davis J, DeSa D, Jamieson D, North P. Skeletal-extraskeletal angiomatosis in a child. International Society for the Study of Vascular Anomalies 15th Congress, Wellington, New Zealand, February 24, 2004. |
52. Shafirstein G, Baumler W, Lapidoth M, North PE, Waner M. Mathematical modeling to suggest optimal FPDL pulse time and wavelengths to treat PWS. International Society for the Study of Vascular Anomalies 15th Congress, Wellington, New Zealand, February 24, 2004. |
53. North PE, DeAos I, Hemphill CH, Waner M, Mihm MC. CCR6 Expression by Endothelial Cells of Infantile Hemanigioma. Society for Pediatric Pathology, Vancouver, British Columbia, March 6, 2004. |
54. Ferguson PE, Oza KK, Ellison DA, North PE, Horn H. Color-matched cassettes and slides decrease specimen handling errors. Mod Pathol 17(S1): 347A, 2004. |
55. Dadras SS, North PE, Bertoncini J, Jackson DG, Mihm MC, and Detmar M. LYVE-1, a novel lymphatic endothelial cell marker, is expressed in infantile hemangiomas. Mod Pathol; 17 (S1):12A, 2004. |
56. G Shafirstein, T Waner, A Mizeracki, CH Hemphill, M Waner, PE North. Living Pig Skin as a Model for Study of Laser-Tissue Interactions in Port-Wine Stain (PWS). Mod Pathol 17(S1): 98A, 2004. |
57. North PE, DeAos I, Lal A, Riggins G, Marchuk DA, Waner M, and Mihm MC. High Expression of Indoleamine 2,3 Deoxygenase in Infantile Hemangioma. Mod Pathol 17(S1): 97A, 2004. |
58. Mukunyadzi P, Zhang F, Fan C-Y, North PE. Utility of GLUT1 Expression in Distinguishing Renal Cell Carcinoma from Adrenal Tumors. United States and Canadian Academy of Pathology, 2005 Annual Meeting, San Antonio, TX Mod Pathol 2005. |
59. Scherer K, Onodera H, DeAos I, Waner M, Buckmiller L, Mihm MC, and North PE. Cellular Senescence and p16 expression in Infantile Hemangioma. Society for Pediatric Pathology, scheduled for 2006 Annual Meeting, Atlanta, GA. Mod Pathol 2006. |
60. Maronn M, Catrine K, North PE, et al. Multifocal Lymphangioendotheliomatosis with Thrombocytopenia:expanding the phenotype. International Society for the Study of Vascular Anomalies 17th Congress, Boston, MA, June 21-24, 2008. |
61. Kumar S, DeAos I, Mihm MC, and North PE. Markedly Elevated Kynurenine/Tryptophan Ratio in Proliferative Phase Infantile Hemangioma: Potential Neurological Implications. International Society for the Study of Vascular Anomalies 17th Congress, Boston, MA, June 21-24, 2008. |
62. Salato V, Wang FW, Kumar S, and North PE. Selective High Expression of the Mesenchymal Homeobox Gene MEOX2 in Endothelial Cells of Infantile Hemangioma and Placenta. International Society for the Study of Vascular Anomalies 17th Congress, Boston, MA, June 21-24, 2008. |
63. Szabo S, Drolet B, Jensen J, and North PE. Early Regressive and Abnormally Persistent Infantile Hemangiomas: Learning from the Extremes. International Society for the Study of Vascular Anomalies 17th Congress, Boston, MA, June 21-24, 2008. |
64. Yang Q, Salato V, Szabo S, Kumar S, Wang FW, Wimpee B, and North PE. A New Ultra-thin Organotypic Slice Model of Infantile Hemangioma (IH) with Sustained Viability and Preserved Endothelial Cell (EC) Phenotype. International Society for the Study of Vascular Anomalies 17th Congress, Boston, MA, June 21-24, 2008. |
65. Sieber F, Muir SA, Cohen EP, North PE, Fish BL, Irving AA, Mader M, Moulder JE. High-dose selenium for the mitigation of radiation injury: a pilot study in a rat model. 54th Annual meeting of the Radiation Research Society, Boston, MA, September 21-24, 2008. |
66. Wilcox DA, Fang J, North P, Nurden P, Nurden AT, Valentin N. High Mortality in Mice with Platelets Expressing Integrin αIIbβ3 Locked-In Its High Affinity State. American Society of Hematology Annual Meeting, San Francisco CA, Dec 6, 2008. |
67. Szabo S, Heaton C, Wimpee B, and North PE. Differential Expression of Infantile Hemangioma (IH)-Associated Antigens along the Normal Placental Vascular Tree and in Placental Chorangiomas. International Society for the Study of Vascular Anomalies 18th Congress, Brussels, Belgium, April 22, 2010. |
68. Sander T, Noll L, Zembles T, Salato V, Webb A, Kumar S, and North PE. Detection of CYP2C19 Single Nucleotide Polymorphisms in Patients with Infantile Hemangioma that Predict Reduced Metabolism of Propranolol, International Society for the Study of Vascular Anomalies 18th Congress, Brussels, Belgium, April 22, 2010. |
69. Yang Q, Kumar S, Salato V, Szabo S, and North PE. Propranolol inhibits proliferation and tube formation by purified placental capillary endothelial cells, an in vitro model for infantile hemangioma (IH), and induces their apoptosis. International Society for the Study of Vascular Anomalies 18th Congress, Brussels, Belgium, April 22, 2010. |
70. Miao Q, North PE et al. Nogo-B Receptor Is Essential for Angiogenesis in Vivo via Akt Pathway, American Heart Association Scientific Sessions, Nov 2010, Chicago, IL(selected as one of the top 10% AHA specialty conference abstracts , 2010). |
71. Weber D, Brosig C, Kumar S, Lerch-Gaggl A, Leigh N, Chun CZ, North P, Peterson T, Ramchandran R. Linking Congenital Cardiovascular Malformations to Neurobehavioral Outcomes in a Zebrafish Model: Preliminary Studies. 4th Annual Pediatric Behavioral Health Research Conference: Building and Sustaining Research Teams, Milwaukee, WI, February 25, 2011. |
72. Worthey E, Taylor B, Jacob H, Schauer D, North P, Sander T, McQuestion G, Bick D, Dimmock D. Experience with the analysis and management of data from whole genome sequencing in clinical practice, annual meeting of the American College of Medical Genetics, March 18, 2011. |
73. Sander T, Wong S, North PE. Pharmacogenetics testing for forensic pathology paves the way for "Personalized Justice" American Society of Investigational Pathology, Washington, DC, April 11, 2011. |
74. Kwon E-K, Siegel DH, Broeckel U, North PE, Worthey E, Chiu YE and Drolet BA. Functional analysis of candidate genes identified by genomewide association study (GWAS) of infantile hemangiomas (IH), annual meeting of the Society for Investigational Dermatology, May, 2011. |
75. Lerch-Gaggl A and North PE. Not Just a Repository - The CRI Pediatric BioBank & Analytical Tissue Core: Making an Impact on Research Studies by Offering Analytical Services to Investigators. Intl Society for Biological & Environmental Repositories Annual Meeting, Vancouver, British Columbia, Canada, May 15-18, 2012. |
76. Yang Q, Kumar S, Salato V, Szabo S and North PE. Propranolol Blocks Autophagy in Infantile Hemangioma (IH) and Human Placental Capillary Endothelial Cells (HPCECs) in vitro, International Society for the Study of Vascular Anomalies 19th Congress, Malmo, Sweden, June, 2012. |
77. Salato V, Yang Q, Scherer K, Wimpee B, Onodera H, Waner M, Tetzlaff J, and North PE. p16INK4a mediated endothelial cell senescence is a fundamental mechanism of spontaneous involution in infantile hemangioma. International Society for the Study of Vascular Anomalies 19th Congress, Malmo, Sweden, June, 2012. |
78. Subramanian S, Chun R, North P, Moe D, Kelly T. Rare submandibular bronchopulmonary foregut cystic malformation mimicking lymphatic malformation. American Society of Neuroradiology annual meeting, May 18, 2013. |
79. North PE. Histopathology of diffuse lymphatic malformation and Gorham's disease. First International Conference on Generalized Lymphatic Anomaly and Gorham-Stout Syndrome, Bethesda, Maryland, June 6, 2013. |
80. Peterson B, Tlomak W, Noll L, North P, Sander T. Use of Pharmacogenetics as an aid in discerning manner of death in oxycodone intoxication. National Association of Medical Examiner's Annual Meeting, Oct 15, 2013. |
81. Runge C, Sander T, Dimmock D, North PE, Lerch-Gaggl A, Friedland D, Kershner J. Development of a Genetic Newborn Hearing Screen Platform, American Society of Pediatric Otolaryngology, May, 2014. |
82. Bachur C, Sachdev M, Connors S, Curatolo A, Shotwell L, North P, Marchuk D, Pevsner J, Moses M, Comi AM. Increased p-ERK expression in leptomeningeal vessels of Sturge Weber syndrome. International Society for the Study of Vascular Anomalies 20th Congress, Melbourne, Australia, April 2, 2014. |
83. Salato V, Yang Q, Comi A, Pevsner J, Gredler J, Gallione C, Marchuk D, and North PE. Identification of Cell Types Harboring GNAQ mutation in Port Wine Stain Tissue. International Society for the Study of Vascular Anomalies 20th Congress, Melbourne, Australia, April 2, 2014. |
84. Sander T, Mitchell A, Mitchell M, Noll L, Mahnke D, Routes J, and North P. Implementation of a Highly-Sensitive and Inexpensive Laboratory Developed Test for 22q11.2 Deletion Syndrome, Association for Molecular Pathology 2015 Meeting, Austin, TX, Nov 3, 2015. |
85. Schwalbe ML, Mrak LN, Gill KG, Pinchot JW, Aagaard- Kienitz BL, Moe D, King D, Buehler D, and North PE. Non-Syndromic Intramuscular Low-Flow Mixed Venous/Lymphatic Malformation of the Extremity (Fibro-Adipose Vascular Anomaly): a Clinicopathologic Study of 23 Cases. 21st International Workshop of the International Society for the Study of Vascular Anomalies, Buenos Aires, Argentina, April 28, 2016. |
86. Alan J. Bergmann, Luis Vasquez, Paula E North, Kim A. Anderson, Passive Sampling in the Alto Mayo. Society of Environmental Toxicology and Chemistry Annual Meeting, November, 2016. |
87. Patents Pending: "Imiquimod Therapies," M Martinez, I Sanchez-Carpintero, MC Mihm, PE North, Application No. PCT/US02/37106. |
88. "Automated Fresh Tissue Sectioning and 3D Reconstruction," G Shafirstein, S Ferguson, L Fink, PE North, and M Waner (UAMS Invention Disclosure I03-18). |
